start-ver=1.4 cd-journal=joma no-vol=18 cd-vols= no-issue=2 article-no= start-page=125 end-page=132 dt-received= dt-revised= dt-accepted= dt-pub-year=2024 dt-pub=202412 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ƒiƒgƒŠƒEƒ€ƒ`ƒƒƒlƒ‹ˆÙí‚Æ‚Ä‚ñ‚©‚ñ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‘åŽçiìú±jˆÉD kn-aut-sei=‘åŽçiìú±j kn-aut-mei=ˆÉD aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwŠwpŒ¤‹†‰@‹³ˆçŠwˆæ END start-ver=1.4 cd-journal=joma no-vol=136 cd-vols= no-issue=1 article-no= start-page=22 end-page=25 dt-received= dt-revised= dt-accepted= dt-pub-year=2024 dt-pub=20240401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Progressive myoclonus epilepsy kn-title=is«ƒ~ƒIƒNƒ[ƒkƒX‚Ä‚ñ‚©‚ñ‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=KobayashiKatsuhiro en-aut-sei=Kobayashi en-aut-mei=Katsuhiro kn-aut-name=¬—ÑŸO kn-aut-sei=¬—Ñ kn-aut-mei=ŸO aut-affil-num=1 ORCID= affil-num=1 en-affil=Department of Pediatrics (Child Neurology), Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University kn-affil=‰ªŽR‘åŠwŠwpŒ¤‹†‰@ˆãŽ•–òŠwˆæ@”­’B_Œo•a‘ÔŠw en-keyword=“‚Ä‚ñ‚©‚ñ kn-keyword=“‚Ä‚ñ‚©‚ñ en-keyword=ƒ~ƒIƒNƒ[ƒkƒX kn-keyword=ƒ~ƒIƒNƒ[ƒkƒX en-keyword=ޏ’² kn-keyword=ޏ’² en-keyword=’m“I‘Þs kn-keyword=’m“I‘Þs en-keyword=ƒ|ƒŠƒOƒ‰ƒt kn-keyword=ƒ|ƒŠƒOƒ‰ƒt END start-ver=1.4 cd-journal=joma no-vol=135 cd-vols= no-issue=3 article-no= start-page=116 end-page=122 dt-received= dt-revised= dt-accepted= dt-pub-year=2023 dt-pub=20231201 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Child neurology and childhood-onset intractable diseases kn-title=¬Ž™_ŒoŠw‚Æ¬Ž™Šú”­Ç“ï•a en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=KobayashiKatsuhiro en-aut-sei=Kobayashi en-aut-mei=Katsuhiro kn-aut-name=¬—ÑŸO kn-aut-sei=¬—Ñ kn-aut-mei=ŸO aut-affil-num=1 ORCID= affil-num=1 en-affil=Department of Pediatrics (Child Neurology), Faculty of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University kn-affil=‰ªŽR‘åŠwŠwpŒ¤‹†‰@ˆãŽ•–òŠwˆæ@”­’B_Œo•a‘ÔŠw en-keyword=Žw’è“ï•a kn-keyword=Žw’è“ï•a en-keyword=¬Ž™–«“Á’èŽ¾Š³ kn-keyword=¬Ž™–«“Á’èŽ¾Š³ en-keyword=”­’B«‚Ä‚ñ‚©‚ñ«”]Ç kn-keyword=”­’B«‚Ä‚ñ‚©‚ñ«”]Ç en-keyword=æ“V«‘ãŽÓˆÙíÇ kn-keyword=æ“V«‘ãŽÓˆÙíÇ END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2005 dt-pub=20050930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Œ‡_”­ì‚ðŽ¦‚·“ú–{l‚Ä‚ñ‚©‚ñгŽÒ‚ÌGABRA1ˆâ“`ŽqAGABRB2ˆâ“`Žq‚¨‚æ‚ÑGABRG2ˆâ“`Žq‰ðÍ kn-title=Mutation screen of GABRA1, GABRB2 and GABRG2 genes in Japanese patients with absence seizures en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=ItoMinako en-aut-sei=Ito en-aut-mei=Minako kn-aut-name=ˆÉ“¡”ü“ÞŽq kn-aut-sei=ˆÉ“¡ kn-aut-mei=”ü“ÞŽq aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2023 dt-pub=20230324 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=¬Ž™Œ‹ß«d‰»ÇгŽÒ‚É‚¨‚¯‚é‚Ä‚ñ‚©‚ñ‚Ì—Õ°Œo‰ß‚Æ“ª”çã”]”g‚Å‹L˜^‚³‚ꂽ‚Žü”gU“®‚Ƃ̒·Šú“I‚ÈŠÖ˜A kn-title=Longitudinal correspondence of epilepsy and scalp EEG fast (40?200 Hz) oscillations in pediatric patients with tuberous sclerosis complex en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=TSUCHIYAHiroki en-aut-sei=TSUCHIYA en-aut-mei=Hiroki kn-aut-name=“y‰®OŽ÷ kn-aut-sei=“y‰® kn-aut-mei=OŽ÷ aut-affil-num=1 ORCID= affil-num=1 en-affil=Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2022 dt-pub=20220325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‚‘¬‰t‘̃Nƒƒ}ƒgƒOƒ‰ƒtƒB[‚ð—p‚¢‚½ŒŒ’†ƒvƒƒ|ƒtƒH[ƒ‹”Z“x‚Ì‘ª’è•û–@‚ÌŠm—§‚ÆR‚Ä‚ñ‚©‚ñ–ò‚ª‘SÖ¬–ƒŒ‚©‚ç‚ÌŠoÁ‚É‹y‚Ú‚·‰e‹¿‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=NakanouMai en-aut-sei=Nakanou en-aut-mei=Mai kn-aut-name=’†”[–ƒˆß kn-aut-sei=’†”[ kn-aut-mei=–ƒˆß aut-affil-num=1 ORCID= affil-num=1 en-affil=Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2020 dt-pub=20200325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Multi-drug therapy for epilepsy influenced on the anesthetic effect of propofol without affecting its pharmacokinetics kn-title=R‚Ä‚ñ‚©‚ñ–ò‚Ì‘½Ü•¹—p‚̓vƒƒ|ƒtƒH[ƒ‹‚Ì–ƒŒŒø‰Ê‚ɉe‹¿‚ð—^‚¦‚邪A–ò•¨“®‘Ԃɂ͉e‹¿‚µ‚È‚¢ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=KodamaMatsuri en-aut-sei=Kodama en-aut-mei=Matsuri kn-aut-name=™Z‹Êää» kn-aut-sei=™Z‹Ê kn-aut-mei=ää» aut-affil-num=1 ORCID= affil-num=1 en-affil=Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2019 dt-pub=20190925 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‚Ä‚ñ‚©‚ñ‚ðŽ‚Â¬Ž™Š³ŽÒ‚Ì•ŸŽƒ§“x—˜—p‚ÌŒ»ó‚Ɖۑè|‘åŠw•a‰@¬Ž™_Œo‰È‚É‚¨‚¯‚éŽÀ‘Ô’²¸| en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=UmenoJunko en-aut-sei=Umeno en-aut-mei=Junko kn-aut-name=”~–ìŽq kn-aut-sei=”~–ì kn-aut-mei=Žq aut-affil-num=1 ORCID= affil-num=1 en-affil=Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È END start-ver=1.4 cd-journal=joma no-vol=130 cd-vols= no-issue=2 article-no= start-page=85 end-page=89 dt-received= dt-revised= dt-accepted= dt-pub-year=2018 dt-pub=20180801 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Drug interaction (42. Drug interaction of new-generation antiepileptic drugs) kn-title=–ò•¨‘ŠŒÝì—pi42\V‹KR‚Ä‚ñ‚©‚ñ–ò‚Ì–ò•¨‘ŠŒÝì—pj en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=TatebeYasuhisa en-aut-sei=Tatebe en-aut-mei=Yasuhisa kn-aut-name=Œš•”‘×® kn-aut-sei=Œš•” kn-aut-mei=‘×® aut-affil-num=1 ORCID= en-aut-name=EsumiSatoshi en-aut-sei=Esumi en-aut-mei=Satoshi kn-aut-name=]ŠpŒå kn-aut-sei=]Šp kn-aut-mei=Œå aut-affil-num=2 ORCID= en-aut-name=KitamuraYoshihisa en-aut-sei=Kitamura en-aut-mei=Yoshihisa kn-aut-name=–k‘º‰À‹v kn-aut-sei=–k‘º kn-aut-mei=‰À‹v aut-affil-num=3 ORCID= en-aut-name=SendoToshiaki en-aut-sei=Sendo en-aut-mei=Toshiaki kn-aut-name=ç“°”Nº kn-aut-sei=ç“° kn-aut-mei=”Nº aut-affil-num=4 ORCID= affil-num=1 en-affil=Department of Pharmacy, Okayama University Hospital kn-affil=‰ªŽR‘åŠw•a‰@@–òÜ•” affil-num=2 en-affil=Department of Pharmacy, Okayama University Hospital kn-affil=‰ªŽR‘åŠw•a‰@@–òÜ•” affil-num=3 en-affil=Department of Pharmacy, Okayama University Hospital kn-affil=‰ªŽR‘åŠw•a‰@@–òÜ•” affil-num=4 en-affil=Department of Pharmacy, Okayama University Hospital kn-affil=‰ªŽR‘åŠw•a‰@@–òÜ•” END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2017 dt-pub=20170324 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=¬Ž™‚̂Ăñ‚©‚ñ‚Æš‹‰ºáŠQ‚Ƃ̊֘A‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=TamechikaYuko en-aut-sei=Tamechika en-aut-mei=Yuko kn-aut-name=਋߂䂤Žq kn-aut-sei=à¨‹ß kn-aut-mei=‚䂤Žq aut-affil-num=1 ORCID= affil-num=1 en-affil=Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University kn-affil=‰ªŽR‘åŠw‘åŠwˆãŽ•–òŠw‘‡Œ¤‹†‰È END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2017 dt-pub=20170324 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=¬Ž™‚Ä‚ñ‚©‚ñгŽÒ‚É‚¨‚¯‚é10”NŠÔ‚Ìfollow-upŒ¤‹†F‚Ä‚ñ‚©‚ñf’f‚ÌŒoŽž“I•ω» kn-title=A ten-year follow-up cohort study of childhood epilepsy: Changes in epilepsy diagnosis with age en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=HanaokaYoshiyuki en-aut-sei=Hanaoka en-aut-mei=Yoshiyuki kn-aut-name=‰Ô‰ª‹`s kn-aut-sei=‰Ô‰ª kn-aut-mei=‹`s aut-affil-num=1 ORCID= affil-num=1 en-affil=Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2017 dt-pub=20170324 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=¬Ž™Šú‚Ì“Á”­«•”•ª‚Ä‚ñ‚©‚ñ‚Ì”]”g‚É‚¨‚¯‚邎ü”gŠˆ“®‚Æž™”gÅ“_‚ÌŠÖŒW«‚ÌŒ¤‹† kn-title=A study on spike focus dependence of high-frequency activity in idiopathic focal epilepsy in childhood en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=ShibataTakashi en-aut-sei=Shibata en-aut-mei=Takashi kn-aut-name=ŽÄ“cŒh kn-aut-sei=ŽÄ“c kn-aut-mei=Œh aut-affil-num=1 ORCID= affil-num=1 en-affil=Graduate School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È END start-ver=1.4 cd-journal=joma no-vol=128 cd-vols= no-issue=3 article-no= start-page=183 end-page=189 dt-received= dt-revised= dt-accepted= dt-pub-year=2016 dt-pub=20161201 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=ElectroencephalographyFan old examination tool with a new meaning for childhood epilepsy kn-title=”]”gF¬Ž™‚Ä‚ñ‚©‚ñ‚É‚¨‚¯‚éŒÃ‚­‚ÄV‚µ‚¢ŒŸ¸ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=KobayashiKatsuhiro en-aut-sei=Kobayashi en-aut-mei=Katsuhiro kn-aut-name=¬—ÑŸO kn-aut-sei=¬—Ñ kn-aut-mei=ŸO aut-affil-num=1 ORCID= affil-num=1 en-affil=Department of Child Neurology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@”­’B_Œo•a‘ÔŠw en-keyword=“ª”ç”]”g kn-keyword=“ª”ç”]”g en-keyword=“_“ª‚Ä‚ñ‚©‚ñ kn-keyword=“_“ª‚Ä‚ñ‚©‚ñ en-keyword=‚Ä‚ñ‚©‚ñŠO‰È kn-keyword=‚Ä‚ñ‚©‚ñŠO‰È en-keyword=‚Žü”gU“® kn-keyword=‚Žü”gU“® en-keyword=ŽžŠÔEŽü”g”•ªÍ kn-keyword=ŽžŠÔEŽü”g”•ªÍ END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2015 dt-pub=20150930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‚Ä‚ñ‚©‚ñ§Œä‚ð‰Â”\‚Æ‚·‚é‘ãŽÓy‘f‚Ì“¯’è en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=SadaNagisa en-aut-sei=Sada en-aut-mei=Nagisa kn-aut-name=²“c kn-aut-sei=²“c kn-aut-mei= aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2015 dt-pub=20150930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=WestÇŒóŒQ‚É‚¨‚¯‚é•›t”玿ŽhŒƒƒzƒ‹ƒ‚ƒ“—Ö@Œã‚̂Ăñ‚©‚ñ«ƒXƒpƒYƒ€‚ÌÄ”­—\‘ªˆöŽq kn-title=Predictive factors for relapse of epileptic spasms after adrenocorticotropic hormone therapy in West syndrome en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=HayashiYumiko en-aut-sei=Hayashi en-aut-mei=Yumiko kn-aut-name=—Ñ—T”üŽq kn-aut-sei=—Ñ kn-aut-mei=—T”üŽq aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ END start-ver=1.4 cd-journal=joma no-vol=126 cd-vols= no-issue=2 article-no= start-page=133 end-page=135 dt-received= dt-revised= dt-accepted= dt-pub-year=2014 dt-pub=20140801 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Treatment for a non-compliant patient with cancer and epilepsy kn-title=Šà’mŒã‚̸_Çó‚ÌŽ¡—Âɓïa‚µ‚½‚Ä‚ñ‚©‚ñŠù‰‚Ì‚ ‚éŠàгŽÒ‚Ì‚P—á en-subtitle= kn-subtitle= en-abstract= kn-abstract=@A 58-year-old man with cervical esophageal cancer and a history of epilepsy was treated with chemoradiotherapy from May of 2013. When tube feeding was initiated due to aspiration pneumonitis, the patient showed a degree of irritability that affected routine staff work and treatment compliance. We attempted to perform supportive care for maladjustment by the notice, the fast, and the tube feeding, but there was no improvement. After we added carbamazepine, primidone, and propericiazine (which had been canceled at the initiation of the tube feeding) to the patient's intravenous phenytoin, the symptoms and treatment compliance improved significantly. We concluded that the causes of the patient's irritability were maladjustment and his epilepsy. en-copyright= kn-copyright= en-aut-name=MinamiDaisuke en-aut-sei=Minami en-aut-mei=Daisuke kn-aut-name=“ì‘å•ã kn-aut-sei=“ì kn-aut-mei=‘å•ã aut-affil-num=1 ORCID= en-aut-name=IchiharaEiki en-aut-sei=Ichihara en-aut-mei=Eiki kn-aut-name=ŽsŒ´‰pŠî kn-aut-sei=ŽsŒ´ kn-aut-mei=‰pŠî aut-affil-num=2 ORCID= en-aut-name=OkabeNobuyuki en-aut-sei=Okabe en-aut-mei=Nobuyuki kn-aut-name=‰ª•”LK kn-aut-sei=‰ª•” kn-aut-mei=LK aut-affil-num=3 ORCID= en-aut-name=YokomichiNaosuke en-aut-sei=Yokomichi en-aut-mei=Naosuke kn-aut-name=‰¡“¹’¼—C kn-aut-sei=‰¡“¹ kn-aut-mei=’¼—C aut-affil-num=4 ORCID= en-aut-name=KougeNoriko en-aut-sei=Kouge en-aut-mei=Noriko kn-aut-name=‚‰º“TŽq kn-aut-sei=‚‰º kn-aut-mei=“TŽq aut-affil-num=5 ORCID= en-aut-name=KajizonoMakoto en-aut-sei=Kajizono en-aut-mei=Makoto kn-aut-name=’bŽ¡‰€½ kn-aut-sei=’bŽ¡‰€ kn-aut-mei=½ aut-affil-num=6 ORCID= en-aut-name=AkimotoYutaka en-aut-sei=Akimoto en-aut-mei=Yutaka kn-aut-name=HŒ³—I kn-aut-sei=HŒ³ kn-aut-mei=—I aut-affil-num=7 ORCID= en-aut-name=HoriKeisuke en-aut-sei=Hori en-aut-mei=Keisuke kn-aut-name=–xŒ\‰î kn-aut-sei=–x kn-aut-mei=Œ\‰î aut-affil-num=8 ORCID= en-aut-name=MatsubaraMinoru en-aut-sei=Matsubara en-aut-mei=Minoru kn-aut-name=¼Œ´–« kn-aut-sei=¼Œ´ kn-aut-mei=–« aut-affil-num=9 ORCID= en-aut-name=NasuJunichiro en-aut-sei=Nasu en-aut-mei=Junichiro kn-aut-name=“ß{~ˆê˜Y kn-aut-sei=“ß{ kn-aut-mei=~ˆê˜Y aut-affil-num=10 ORCID= en-aut-name=TanimotoMitsune en-aut-sei=Tanimoto en-aut-mei=Mitsune kn-aut-name=’J–{Œõ‰¹ kn-aut-sei=’J–{ kn-aut-mei=Œõ‰¹ aut-affil-num=11 ORCID= en-aut-name=KiuraKatsuyuki en-aut-sei=Kiura en-aut-mei=Katsuyuki kn-aut-name=–؉YŸs kn-aut-sei=–؉Y kn-aut-mei=Ÿs aut-affil-num=12 ORCID= en-aut-name=MatsuokaJunzi en-aut-sei=Matsuoka en-aut-mei=Junzi kn-aut-name=¼‰ª‡Ž¡ kn-aut-sei=¼‰ª kn-aut-mei=‡Ž¡ aut-affil-num=13 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@ŠÉ˜aŽxŽˆã—Ã‰È affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@ŒŒ‰tEŽîá‡EŒÄ‹zŠí“à‰È affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@¸_‰È_Œo‰È affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@ŠÉ˜aŽxŽˆã—Ã‰È affil-num=5 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@ŠÅŒì•” affil-num=6 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@–òÜ•” affil-num=7 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@Á‰»Ší“à‰È affil-num=8 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@Á‰»Ší“à‰È affil-num=9 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@Á‰»Ší“à‰È affil-num=10 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@Á‰»Ší“à‰È affil-num=11 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@ŒŒ‰tEŽîá‡EŒÄ‹zŠí“à‰È affil-num=12 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@ŒŒ‰tEŽîá‡EŒÄ‹zŠí“à‰È affil-num=13 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@ŠÉ˜aŽxŽˆã—Ã‰È en-keyword=‚Ä‚ñ‚©‚ñiepilepsyj kn-keyword=‚Ä‚ñ‚©‚ñiepilepsyj en-keyword=ˆÕ“{«iirritabilityj kn-keyword=ˆÕ“{«iirritabilityj en-keyword=“K‰žáŠQimaladjustmentj kn-keyword=“K‰žáŠQimaladjustmentj END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2014 dt-pub=20140325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Scn1aˆâ“`Žq•ψك‰ƒbƒg‚ð—p‚¢‚½R‚Ä‚ñ‚©‚ñ–ò‚Ì”M«‚¯‚¢‚ê‚ñ—}§Œø‰Ê kn-title=Therapy for hyperthermia-induced seizures in Scn1a mutant rats en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=HayashiKeiichiro en-aut-sei=Hayashi en-aut-mei=Keiichiro kn-aut-name=—ÑŒjˆê˜Y kn-aut-sei=—Ñ kn-aut-mei=Œjˆê˜Y aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol=126 cd-vols= no-issue=1 article-no= start-page=55 end-page=58 dt-received= dt-revised= dt-accepted= dt-pub-year=2014 dt-pub=20140401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Clinical guideline for epilepsy kn-title=‚Ä‚ñ‚©‚ñŽ¡—ÃKƒCƒhƒ‰ƒCƒ“‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=MorimotoNobutoshi en-aut-sei=Morimoto en-aut-mei=Nobutoshi kn-aut-name=X–{“W”N kn-aut-sei=X–{ kn-aut-mei=“W”N aut-affil-num=1 ORCID= en-aut-name=AbeKoji en-aut-sei=Abe en-aut-mei=Koji kn-aut-name=ˆ¢•”N“ñ kn-aut-sei=ˆ¢•” kn-aut-mei=N“ñ aut-affil-num=2 ORCID= affil-num=1 en-affil= kn-affil=쌧—§’†‰›•a‰@@_Œo“à‰È affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@”]_Œo“à‰ÈŠw END start-ver=1.4 cd-journal=joma no-vol=11 cd-vols= no-issue=2 article-no= start-page=163 end-page=173 dt-received= dt-revised= dt-accepted= dt-pub-year=1993 dt-pub=199306 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=¬Ž™Šú‚É‚¨‚¯‚é’x”­«‚Ä‚ñ‚©‚ñ‚Ì—Õ°“I”]”gŠw“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‘å“ú•ûC kn-aut-sei=‘å“ú•û kn-aut-mei=C aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol=124 cd-vols= no-issue=2 article-no= start-page=115 end-page=117 dt-received= dt-revised= dt-accepted= dt-pub-year=2012 dt-pub=20120801 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Therapy for hyperthermia-induced seizures in Scn1a mutant rats kn-title=Scn1aˆâ“`Žq•ψك‰ƒbƒg‚ð—p‚¢‚½R‚Ä‚ñ‚©‚ñ–ò‚Ì”M«‚¯‚¢‚ê‚ñ—}§Œø‰Ê en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=HayashiKeiichiro en-aut-sei=Hayashi en-aut-mei=Keiichiro kn-aut-name=—ÑŒjˆê˜Y kn-aut-sei=—Ñ kn-aut-mei=Œjˆê˜Y aut-affil-num=1 ORCID= en-aut-name=OhmoriIori en-aut-sei=Ohmori en-aut-mei=Iori kn-aut-name=‘åŽçˆÉD kn-aut-sei=‘åŽç kn-aut-mei=ˆÉD aut-affil-num=2 ORCID= en-aut-name=MatsuiHideki en-aut-sei=Matsui en-aut-mei=Hideki kn-aut-name=¼ˆäGŽ÷ kn-aut-sei=¼ˆä kn-aut-mei=GŽ÷ aut-affil-num=3 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@×–E¶—Šw affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@×–E¶—Šw affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@×–E¶—Šw en-keyword=febrile seizures kn-keyword=febrile seizures en-keyword=animal model kn-keyword=animal model en-keyword=Scn1a gene kn-keyword=Scn1a gene en-keyword=generalized epilepsy with febrile seizures plus kn-keyword=generalized epilepsy with febrile seizures plus en-keyword=severe myoclonic epilepsy of infancy kn-keyword=severe myoclonic epilepsy of infancy END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2012 dt-pub=20120323 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=áŠQŽÒŽ•‰ÈŽ¡—ÃŽž‚Ì‘Sg–ƒŒ‚É‚¨‚¢‚ÄR‚Ä‚ñ‚©‚ñ–ò‚Ì•ž—p‚ªÃ–¬“à“Š—^‚µ‚½ƒ~ƒ_ƒ]ƒ‰ƒ€‚Ì–ò•¨“®‘Ô‚É‹y‚Ú‚·‰e‹¿ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=HayashiTomoko en-aut-sei=Hayashi en-aut-mei=Tomoko kn-aut-name=—Ñ’mŽq kn-aut-sei=—Ñ kn-aut-mei=’mŽq aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol=123 cd-vols= no-issue=2 article-no= start-page=91 end-page=95 dt-received= dt-revised= dt-accepted= dt-pub-year=2011 dt-pub=20110801 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=A long-term follow-up study of Dravet syndrome up to adulthood kn-title=¬lŠú‚É’B‚µ‚½DravetÇŒóŒQ‚Ì’·ŠúŒo‰ß‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=AkiyamaMari en-aut-sei=Akiyama en-aut-mei=Mari kn-aut-name=HŽR–ƒ—¢ kn-aut-sei=HŽR kn-aut-mei=–ƒ—¢ aut-affil-num=1 ORCID= en-aut-name=KobayashiKatsuhiro en-aut-sei=Kobayashi en-aut-mei=Katsuhiro kn-aut-name=¬—ÑŸO kn-aut-sei=¬—Ñ kn-aut-mei=ŸO aut-affil-num=2 ORCID= en-aut-name=YoshinagaHarumi en-aut-sei=Yoshinaga en-aut-mei=Harumi kn-aut-name=‹g‰iŽ¡”ü kn-aut-sei=‹g‰i kn-aut-mei=Ž¡”ü aut-affil-num=3 ORCID= en-aut-name=OhtsukaYoko en-aut-sei=Ohtsuka en-aut-mei=Yoko kn-aut-name=‘å’ËèñŽq kn-aut-sei=‘å’Ë kn-aut-mei=èñŽq aut-affil-num=4 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@”­’B_Œo•a‘ÔŠw affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@”­’B_Œo•a‘ÔŠw affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@”­’B_Œo•a‘ÔŠw affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@”­’B_Œo•a‘ÔŠw en-keyword=DravetÇŒóŒQ kn-keyword=DravetÇŒóŒQ en-keyword=“ûŽ™dǃ~ƒIƒNƒƒj[‚Ä‚ñ‚©‚ñ kn-keyword=“ûŽ™dǃ~ƒIƒNƒƒj[‚Ä‚ñ‚©‚ñ en-keyword=—\Œã kn-keyword=—\Œã en-keyword=‚¯‚¢‚ê‚ñ«‚Ä‚ñ‚©‚ñdÏó‘Ô kn-keyword=‚¯‚¢‚ê‚ñ«‚Ä‚ñ‚©‚ñdÏó‘Ô END start-ver=1.4 cd-journal=joma no-vol=123 cd-vols= no-issue=1 article-no= start-page=59 end-page=62 dt-received= dt-revised= dt-accepted= dt-pub-year=2011 dt-pub=20110401 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Drug interaction (20. combination with enteral nutrition formulas) kn-title=–ò•¨‘ŠŒÝì—pi20\Œo’°‰h—{܂̖ò•¨‘ŠŒÝì—pj en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=TairaKentaro en-aut-sei=Taira en-aut-mei=Kentaro kn-aut-name=•½Œ’‘¾˜Y kn-aut-sei=•½ kn-aut-mei=Œ’‘¾˜Y aut-affil-num=1 ORCID= en-aut-name=MatsunagaHisashi en-aut-sei=Matsunaga en-aut-mei=Hisashi kn-aut-name=¼‰i® kn-aut-sei=¼‰i kn-aut-mei=® aut-affil-num=2 ORCID= en-aut-name=SendoToshiaki en-aut-sei=Sendo en-aut-mei=Toshiaki kn-aut-name=ç“°”Nº kn-aut-sei=ç“° kn-aut-mei=”Nº aut-affil-num=3 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@–òÜ•” affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@–òÜ•” affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw•a‰@@–òÜ•” END start-ver=1.4 cd-journal=joma no-vol=102 cd-vols= no-issue=3-4 article-no= start-page=453 end-page=463 dt-received= dt-revised= dt-accepted= dt-pub-year=1990 dt-pub=199004 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Acetylcholine turnover on the experimental epileptic focus of the rat cerebral cortex kn-title=“SƒCƒIƒ“”]“à’“ü‚É‚æ‚éŽÀŒ±“I‚Ä‚ñ‚©‚ñŒ´«Å“_‘gD‚É‚¨‚¯‚éacetylcholine‘ãŽÓ‚ÌŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=The effect of iron ion injection on acetylcholine (ACh) turnover was studied in the cerebral cortex of male Sprague-Dawley rats. Rats were divided into 3 groups: rats of the Fe-group were injected with 500 nmol of Fe(3+) in the left sensorimotor cortex, rats of the HCl-group were injected with HCl-acidified saline (pH 1.8) in the left sensorimotor cortex, and a shamoperated group acted as a control (Sham-group). On both sides of the cortex, the choline acetyltransferase (CAT) activity of the HCI- and Fe-groups decreased 30 min after, increased 6h after, and then decreased 24h after the injection compared with the activity of the Sham-group. A no time was there any difference between the CAT activities of the HCl- and Fe-groups. On both sides of the cortex, the ACh content of the HCl- and Fe-groups decreased transiently 24h after injection, but there was no difference in ACh content between the two groups. In the left cortex of the Fe- and HCl-groups, acetylcholinesterase (AChE) activity, which showed no difference between the two groups, decreased 30 min after injection. These findings suggested that cortical neurons especially AChergic neurons might be irritated by a transient increase in intracranial pressure due to brain edema induced by the injection of acid into the cortex, as no specific effct of Fe(3+)-injection was observed in this study. en-copyright= kn-copyright= en-aut-name=KawakamiYunosuke en-aut-sei=Kawakami en-aut-mei=Yunosuke kn-aut-name=‰Íã—Y”V‰î kn-aut-sei=‰Íã kn-aut-mei=—Y”V‰î aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•””]‘ãŽÓŒ¤‹†Ž{Ý‹@”\¶‰»Šw•”–å en-keyword=acetylcholine turnover kn-keyword=acetylcholine turnover en-keyword=head injury kn-keyword=head injury en-keyword=choline acetyltransferase kn-keyword=choline acetyltransferase en-keyword=cholinesterase kn-keyword=cholinesterase en-keyword=brain edema kn-keyword=brain edema END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ƒ‰ƒbƒg‚ÌŠO‘¤•Gó‘̃Lƒ“ƒhƒŠƒ“ƒO‚É‚æ‚è¶‚¸‚éŒõ—U”­“dˆÊ‚̕ω»‚¨‚æ‚ÑR‚Ä‚ñ‚©‚ñ–ò‚ÌŒø‰Ê‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=IshikawaTakashi en-aut-sei=Ishikawa en-aut-mei=Takashi kn-aut-name=Îì’ kn-aut-sei=Îì kn-aut-mei=’ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2010 dt-pub=20100325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=ƒGƒŠƒXƒƒ|ƒGƒ`ƒ“‚ÌR‚Ä‚ñ‚©‚ñì—pFƒjƒ…[ƒƒyƒvƒ`ƒhY‚ÌŠˆ«‰»‚ÆŠC”nŽ•ó‰ñ‚É‚¨‚¯‚éˆÙí‚È_ŒoV¶‚Ì—}§‚ÆŠÖ˜A‚µ‚Ä kn-title=Erythropoietin exerts anti-epileptic effects with the suppression of aberrant new cell formation in the dentate gyrus and upregulation of neuropeptide Y in seizure model of rats en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=KondoAkihiko en-aut-sei=Kondo en-aut-mei=Akihiko kn-aut-name=‹ß“¡‘•F kn-aut-sei=‹ß“¡ kn-aut-mei=‘•F aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol=6 cd-vols= no-issue= article-no= start-page=18 end-page=23 dt-received= dt-revised= dt-accepted= dt-pub-year=1988 dt-pub=198804 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‚Ä‚ñ‚©‚ñƒ‚ƒfƒ‹ƒ}ƒEƒXiE1, CBA, AKR, A/St, IDT, ICRƒ}ƒEƒXj en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=KatayamaYasuto en-aut-sei=Katayama en-aut-mei=Yasuto kn-aut-name=•ÐŽR‘×l kn-aut-sei=•ÐŽR kn-aut-mei=‘×l aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•””]‘ãŽÓŒ¤‹†Ž{Ý‹@”\¶‰»Šw•”–å END start-ver=1.4 cd-journal=joma no-vol=73 cd-vols= no-issue=10-12 article-no= start-page=785 end-page=789 dt-received= dt-revised= dt-accepted= dt-pub-year=1961 dt-pub=19611230 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Metabolism of ƒÁ-Aminobutyric Acid Part 3. Transamilase Activity in Epileptic Brain kn-title=ƒÁ-ƒAƒ~ƒm—Ž_‚Ì‘ãŽÓ‚ÉŠÖ‚·‚錤‹† ‘æ3•Ò ‚Ä‚ñ‚©‚ñ”]‚ÌtransaminaseŠˆ«‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract=A genuine epileptic and experimental animals such as L. C. L. A. rabbit, ep-mouse and vitamin B(6) deficient mouse were utilized for this study to measure the transamilase activity. 1) The focus in the epileptic brain manifested the decrease of the transamilase activity compared with the non-focus and also the non epileptic. 2) There was, however, no significant difference between the transamilase activities of the epileptic non-focus and of the non-epileptic. 3) In both cases of L. C. L. A. rabbit and ep-mouse, no difference could be found in the activity in contrast to the control groups. 4) The transamilase activity of the VB(6) deficient mouse brain was seemed to be considerably decreased in contrast to the control. en-copyright= kn-copyright= en-aut-name=UnoKazuaki en-aut-sei=Uno en-aut-mei=Kazuaki kn-aut-name=‰F–ì˜a¹ kn-aut-sei=‰F–ì kn-aut-mei=˜a¹ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æ1iw“àjŠO‰È‹³Žº END start-ver=1.4 cd-journal=joma no-vol=73 cd-vols= no-issue=10-12 article-no= start-page=777 end-page=784 dt-received= dt-revised= dt-accepted= dt-pub-year=1961 dt-pub=19611230 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Metabolism of ƒÁ-Aminobutyric Acid Part 2. Metabolism of (14)C-ƒÁ-Aminobutyric Acid in an Epileptic Brain Slice kn-title=ƒÁ-ƒAƒ~ƒm—Ž_‚Ì‘ãŽÓ‚ÉŠÖ‚·‚錤‹† ‘æ2•Ò ‚Ä‚ñ‚©‚ñ”]ؕЂɂæ‚é(14)C-ƒÁ-Aminobutyric aicd‚Ì‘ãŽÓ‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract=Studies were carried out to clearfy GABA metabolism in the brains of an epileptic, the latent cerebral local anaphylactic (L. C. L. A.) rabbit and ep-mouse administered with (14)C-GABA. 1) Incubated with a brain slice, radioactivity of (14)C-GABA was slightly detected in glutamic acid, aspartic acid and glutamine in the incubation medium. 2) In this case, most of the radioactive carbon of GABA was converted into (14)CO(2). 3) The epileptic brain appeared to decreased in the (14)CO(2)-activity, compared with the non-epileptic. In case of the epileptic brain, the activity in the focus was lower than the one in the non-focus. 4) The study with L. C. L. A. rabbit and ep-mouse could not manifest any difference in GAGA metabolism in contrast to the normal control groups. en-copyright= kn-copyright= en-aut-name=UnoKazuaki en-aut-sei=Uno en-aut-mei=Kazuaki kn-aut-name=‰F–ì˜a¹ kn-aut-sei=‰F–ì kn-aut-mei=˜a¹ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æ1iw“àjŠO‰È‹³Žº END start-ver=1.4 cd-journal=joma no-vol=73 cd-vols= no-issue=1-3 article-no= start-page=153 end-page=157 dt-received= dt-revised= dt-accepted= dt-pub-year=1961 dt-pub=19610330 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Biochemical Studies on Vitamin B(6) Deficient Mouse Brain in Experimental Epilepsy Part 2. A study on free amino acids in the B(6) deficient mouse brain kn-title=ŽÀŒ±“I‚Ä‚ñ‚©‚ñǂƂµ‚Ẵrƒ^ƒ~ƒ“B(6)Œ‡–Rƒ}ƒEƒX”]‚̶‰»Šw“IŒ¤‹† ‘æ2•Ò ƒrƒ^ƒ~ƒ“B(6)Œ‡–Rƒ}ƒEƒX”]‚Ì—V—£ƒAƒ~ƒmŽ_‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract=Using mice with chronic B(6) deficiency induced by B(6) deficient diet and other group of mice with acute B(6) deficiency induced by the intravenous injection of desoxypyridoxine, the author carried out quantitative analysis of free amino acids in the cerebral cortex of these animals, and obtained the following results. 1. In both groups with acute and chronic B(6) deficiency glutamic acid is markedly iucreased, but no significant change can be recognized in the quantity of ƒÁ-aminobutyric acid (GABA). 2. An increase of glycerophoethanolamine and phosphoethanolamine can be recognized in the group with B(6) deficiency. 3. In the group given the intravenous injection of desoxypyridoxine there can be observed an increase in alanine, glycine and valine. 4. Cystathionine is increased in the group with B(6) deficiency. 5. In comparing the results of assay of free amino acids in the B(6) deficient mouse brain with those of idiopathic human epileptic brain, there seems to be no direct connection between human idiopathic epilepsy and B(6) deficiency. en-copyright= kn-copyright= en-aut-name=MatanoSakae en-aut-sei=Matano en-aut-mei=Sakae kn-aut-name=–“–ì‰h kn-aut-sei=–“–ì kn-aut-mei=‰h aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æ1iw“àjŠO‰È‹³Žº END start-ver=1.4 cd-journal=joma no-vol=73 cd-vols= no-issue=1-3 article-no= start-page=145 end-page=151 dt-received= dt-revised= dt-accepted= dt-pub-year=1961 dt-pub=19610330 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Biochemical Studies on Vitamin B(6) Deficient Mouse Brain in Experimental Epilepsy Part 1. The cholinesterase activity, and the contents of Na, K, and water in vitamin B(6) deficient mouse cerebrum kn-title=ŽÀŒ±“I‚Ä‚ñ‚©‚ñǂƂµ‚Ẵrƒ^ƒ~ƒ“B(6)Œ‡–Rƒ}ƒEƒX”]‚̶‰»Šw“IŒ¤‹† ‘æ1•Ò ƒrƒ^ƒ~ƒ“B(6)Œ‡–Rƒ}ƒEƒX‘å”]‚ÌCholinesteraseŠˆ«’lCNaCKŠÜ—L—Ê‚¨‚æ‚ÑŠÜ…—ʂɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract=With young mice fed on B(6) deficient synthetic food for 30 days the author observed general conditions of these animals and also carried out biochemical studies on their cerebral cortex. Some of them were subjected to intravenous injection of desoxypyridoxine, known to possess competitive action against B(6), and changes in their cerebrum were investigated. The follwing are the results of the present study. 1. In the mice fed on B(6) deficient food the gain in the body weight is inhibited when compared with the control group kept on normal diet. More than one month later these B(6) deficient animals show the falling off of hairs and reddening around their mouth and the coarsening of body hairs. 2. In the mice fed on B(6) deficient food a definite decrease in cholinesterase activity (ChE) can be observed in their cerebral cortex when compared with the control group. In those with experimental epilepsy elicited by the intravenous injection of desoxypyridoxine, a marked diminution of ChE can be recognized. 3. While there can be seen no significant difference in the contents of Na and K in the cerebral cortex of the mice fed on B(6) deficient food when compared with those of the control an increase of Na and a decrease of K can be recognized in those animals with epilepsy induced by the intravenous injection of desoxypyirdoxine. 4. In the micc fed on B(6) deficient food there can also observed an increase in free water of the cerebral cortex. en-copyright= kn-copyright= en-aut-name=MatanoSakae en-aut-sei=Matano en-aut-mei=Sakae kn-aut-name=–“–ì‰h kn-aut-sei=–“–ì kn-aut-mei=‰h aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æ1iw“àjŠO‰È‹³Žº END start-ver=1.4 cd-journal=joma no-vol=75 cd-vols= no-issue=7-9 article-no= start-page=675 end-page=693 dt-received= dt-revised= dt-accepted= dt-pub-year=1963 dt-pub=19630930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Localization Study of Epileptogenic Focus by Means of Intracarotid Sodium Amobarbital Injection Part 111 Differentiation of Primary and Secondary Bilaterally Synchronous Spike and Wave Complex kn-title=ƒAƒ‚ƒoƒ‹ƒrƒ^[ƒ‹ƒ\[ƒ_èò“®–¬’ŽË‚É‚æ‚é‚Ä‚ñ‚©‚ñÅ“_‹ÇÝf’f‚ÉŠÖ‚·‚錤‹† ‘æ3•Ò 1ŽŸ“I‹y‚Ñ2ŽŸ“I—¼‘¤“¯Šú«ž™™”g•¡‡‚̊ӕʂɊւ·‚é—Õ°“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=Intracarotid injection of 50 to 100 mg of 5 to 10 % sodium amobarbital was given to 30 cases of epileptics, and change of the abnormal EEG was followed. 1) Unilateral focal cortical epileptogenic spikes were abolished by the ipsilateral administration, but not by the contralateral. 2) Amongst the cases of bilaterally synchronous spike and wave complex, two types of marked responses were obtained at the administration. One group manifested an abolishment of the complex from all leads of both hemispheres by administration on one side, but a transient inhibition of the spike component from the ipsilateral hemisphere by administration on the other side. This appears to indicate the complex originates from unilateral cortical focus which is located at the first side. This group may correspond with the secondary bilateral synchrony. 3) Another group manifested a transient inhibition of the spike component from ipsilateral hemisphere without abolishment of the complex at either side of administration. This may correspond with the primary bilateral synchrony, the so-called "ceutrencephalic origin". 4) No activation of characteristic abnormal activities in epileptics was found at the intracarotid injection of sodium amobarbital. en-copyright= kn-copyright= en-aut-name=YagiTakashi en-aut-sei=Yagi en-aut-mei=Takashi kn-aut-name=”ª–ØŒ’ kn-aut-sei=”ª–Ø kn-aut-mei=Œ’ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æ1ŠO‰È‹³Žº END start-ver=1.4 cd-journal=joma no-vol=75 cd-vols= no-issue=7-9 article-no= start-page=665 end-page=673 dt-received= dt-revised= dt-accepted= dt-pub-year=1963 dt-pub=19630930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Localization Study of Epileptogenic Focus by Means of Intracarotid Sodium Amobarbital Injection Part 11 Intracarotid Sodium Amobarbital Injection Effect on Human EEG kn-title=ƒAƒ‚ƒoƒ‹ƒrƒ^[ƒ‹ƒ\[ƒ_èò“®–¬’ŽË‚É‚æ‚é‚Ä‚ñ‚©‚ñÅ“_‹ÇÝf’f‚ÉŠÖ‚·‚錤‹† ‘æ2•Ò ƒAƒ‚ƒoƒ‹ƒrƒ^[ƒ‹ƒ\[ƒ_èò“®–¬’ŽË‚Ì”]”gŠî‘b—¥“®‚É‹y‚Ú‚·‰e‹¿‚ÉŠÖ‚·‚é—Õ°“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=An attempt was made to analyze the changes of EEG secondary to the intracarotid injection of 50 to 100 mg of sodium amobarbital: 33 trials on 20 patients. 1) There appeared to be a marked change in all cases; limited or dominant ipsilaterally to the side of administration. 2) The latter was found in 22 out of 33 trials, and noted at the records of the frontal leads. 3) The change was composed of high amplitude and low frequency or of low amplitude and high frequency or of the mixed of both, occurring at 3 to 6 seconds after the onset of the injection and gradually disappearing to regain the normal state within 30 minutes. 4) These changes, especially the high amplitude and slow waves immediately after the injection at the same side were markedly noticed when the injection was in large dosage and in high speed. 5) There was no difference in such changes given arise by either side of administration in the same patient. 6) It is to be noted that there were no hazardous complications at the intracarotid injection of 10 % sodium amobarbital under sufficient attention. en-copyright= kn-copyright= en-aut-name=YagiTakeshi en-aut-sei=Yagi en-aut-mei=Takeshi kn-aut-name=”ª–ØŒ’ kn-aut-sei=”ª–Ø kn-aut-mei=Œ’ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æ1ŠO‰È‹³Žº END start-ver=1.4 cd-journal=joma no-vol=75 cd-vols= no-issue=7-9 article-no= start-page=649 end-page=663 dt-received= dt-revised= dt-accepted= dt-pub-year=1963 dt-pub=19630930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Localization Study of Epileptogenic Focus by Means of Intracarotid Sodium Amobarbital Injection Part 1 Intracarotid Sodium Amobarbital Injection Effect on Experimentally Produced Focal Epileptogenic Discharge of Cat kn-title=ƒAƒ‚ƒoƒ‹ƒrƒ^[ƒ‹ƒ\[ƒ_èò“®–¬’ŽË‚É‚æ‚é‚Ä‚ñ‚©‚ñÅ“_‹ÇÝf’f‚ÉŠÖ‚·‚錤‹† ‘æ1•Ò ŽÀŒ±“I‚Ä‚ñ‚©‚ñÅ“_‚ɑ΂·‚éƒAƒ‚ƒoƒ‹ƒrƒ^[ƒ‹ƒ\[ƒ_èò“®–¬’ŽË‚̉e‹¿‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=Twenty adult cats were utilized for this study under unanesthetized condition. Penicillin was locally given in various parts of cortex and subcortical nucleus or thalamus to elicit epileptogenic discharges and sodium amobarbital was intracarotidly injected to give arise transient functional depression of hemisphere. EEG was followed up in the course of this experiment. 1) Local application of penicillin into cortex or subcortical nucleus or thalamus considerably elicited epileptogenic discharges. 2) In case of focal cortical epileptogenic discharge, the first spike appearing at the neighbouring area of the focus was followed to be associated with the synchronous spike discharge at the opposite side and then the focal seizure discharge was built. The discharge was occaionally interrupted by the interictal state, building, in some of the cases, the final stage of generalized seizure discharge. 3) So was noted in its appearance and process in case of focal subcortical epileptogenic discharge. But there was a more tendency of transmission of its activity to the opposite side in comparison with the cortical epileptogenic discharge. 4) The epileptogenic discharge originated from unilateral cortical focus was abolished or inhibited by means of ipsilateral intracarotid injection of 5 to 10 mg sodium amobarbital, but was not affected by the contralateral administration. However, either side of the injection could not inhibit the discharge activity after it became a focal seigure discharge. 5) Subcortically elicited epileptogenic discharge, in contrast, could not be interfered by either side of the intracarotid administration. 6) In cases of both focal cortical and subcortical discharge, intracarotid injection of sodium amobarbital manifested a tendency of flattening and slowing of back ground activity at the injected side, but not at the opposide side. 7) The intracarotid administration could not activate the epileptogenic discharges either from cortex and subcortex. en-copyright= kn-copyright= en-aut-name=YagiTakeshi en-aut-sei=Yagi en-aut-mei=Takeshi kn-aut-name=”ª–ØŒ’ kn-aut-sei=”ª–Ø kn-aut-mei=Œ’ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æ1ŠO‰È‹³Žº END start-ver=1.4 cd-journal=joma no-vol=72 cd-vols= no-issue=2 article-no= start-page=515 end-page=520 dt-received= dt-revised= dt-accepted= dt-pub-year=1960 dt-pub=19600130 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Transaminase of Brain (‡U) Effects of Psychotropic and Neurotropic Drugs on the Transaminase Activities kn-title=”]‚̃gƒ‰ƒ“ƒXƒAƒ~ƒi[ƒ[ ‘æ2•Ò ŠeŽíŒü¸_E_Œo–ò‚̃_ƒCƒRƒNƒlƒYƒ~”]‘gDƒgƒ‰ƒ“ƒXƒAƒ~ƒi[ƒ[Šˆ«‚É‹y‚Ú‚·‰e‹¿ en-subtitle= kn-subtitle= en-abstract=Effects of 18 psychotropic and 3 neurotropic drugs were measured by the author on the glutamic-aspartic transaminase (GAT) activities in the rat brain homogenates. 1. Chlorpromazine, chlopromazine sulfoxide, acetylpromazine, levomepromazine, mepazine and perphenazine inhibited GAT, while prochlorperazine showed no effect. Both of diethazine and promethazine did not effect on GAT. 2. Pipradrol and dimethylaminoethanol activated GAT, while methylphenidate showed no effect. 3. Azacyclonol, amobarbital, phenobarbital, methyprylon, glutethimide and primidone were inhibitory in acion on GAT. 4. LSD-25 inhibited to GAT and bemegride did not effect on. 5. In the effect on GAT, similarities of imipramine to the phenothiazine derived depressants, or differences of diethazine and promethazine from other phenothiazine derivatives seemed to be causad due to the resemble or different distance between two nitrogen atoms. kn-abstract=ƒ_ƒCƒRƒNƒlƒYƒ~”]homogenate‚ð—p‚¢CƒOƒ‹ƒ^ƒ~ƒ“Ž_-ƒAƒXƒpƒ‰ƒMƒ“Ž_ƒgƒ‰ƒ“ƒXƒAƒ~ƒi[ƒ[iGATjŠˆ«‚É‹y‚Ú‚·18Ží‚ÌŒü¸_–òC‚¨‚æ‚Ñ3Ží‚ÌŒü_Œo–ò‚̉e‹¿‚𑪒肵‚½. 1. ƒtƒGƒmƒ`ƒAƒWƒ“ŒnŒü¸_–ò‚ÍC Prochlorperazine‚𜂭‘¼‚Ì6Ží‚Í‚¢‚¸‚ê‚àGAT‘jŠQ‚ðŽ¦‚µC‘jŠQì—p‚ÍChlorpromazine‚ÉÅ‚à‹­‚©‚‚½. Chlorpromazine S-oxide‚ÍChlorpromazine‚ɔ䂵‚ÄGAT‘jŠQì—p‚Í’˜‚µ‚­Žã‚¢. 2Ží‚̃tƒGƒmƒ`ƒAƒWƒ“ŒnŒü_Œo–ò‚ÍGATŠˆ«‚ɉe‹¿‚ð‚݂Ȃ©‚‚½. 2. Azacyclonol‚ÍGAT‘jŠQ‚ðŽ¦‚µC LSD-25‚Í‚”Z“x‚Å‘jŠQ‚ðŽ¦‚µ‚½‚ª’á”Z“x‚ł͉e‹¿‚ð—^‚¦‚È‚©‚‚½. 3. ’†•ŽhŒÜ4Ží‚Ì‚¤‚¿C Pipradrol‚ÆDMAE‚Í‘£iC Methylphenidate‚͉e‹¿‚È‚­C Tofranil‚Í‘jŠQ‚ðŽ¦‚µ‚½. 4. ƒoƒ‹ƒrƒc[ƒ‹Ž_Œn‡–°ÜAmobarbital‚ÆPhenobarbitalC”ñƒoƒ‹ƒrƒc[ƒ‹Ž_Œn‡–°ÜMethyprylon‚ÆGlutethimide‚ÍC‚·‚ׂđjŠQ‚ðŽ¦‚µ‚½.‚µ‚©‚é‚Ƀoƒ‹ƒrƒc[ƒ‹Ž_hRÜBemegride‚ÍGAT‚É–³‰e‹¿‚Å‚ ‚‚½.R‚Ä‚ñ‚©‚ñÜPrimidone‚Í‘jŠQ‚ðŽ¦‚µ‚½. 5. ŽÀŒ±‚É—p‚¢‚½’†•—}§Ü13Ží‚Ì‚¤‚¿12Ží‚ª‘jŠQ‚ðŽ¦‚µ‚½. 6. GAT‚É‹y‚Ú‚·ì—p‚É‚¨‚¢‚ÄC Imipramine‚ÆChlorpromazine‚Ì—ÞŽ—C Diethazine‚âPromethazine‚ÆChlorpromazine‚Ƃ̷ˆÙ‚ðC‰»Šw\‘¢‚É‚¨‚¯‚é2ŒÂ‚ÌNŒ´ŽqŠÔ‚Ì‹——£‚̈ê’v‚Æ‘ŠˆÙ‚É‘Î‰ž‚·‚邯l‚¦‚½. en-copyright= kn-copyright= en-aut-name=OnoMasaya en-aut-sei=Ono en-aut-mei=Masaya kn-aut-name=¬–ì¹–ç kn-aut-sei=¬–ì kn-aut-mei=¹–ç aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”_Œo¸_ˆãŠw‹³Žº END start-ver=1.4 cd-journal=joma no-vol=74 cd-vols= no-issue=8-9 article-no= start-page=629 end-page=634 dt-received= dt-revised= dt-accepted= dt-pub-year=1962 dt-pub=19620930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Studies on Glutamic Decarboxylase in the Brain ‡U. Glutamic Decarboxyase Activity of Epileptogenic Cerebral Cortex kn-title=”]‚Ìglutamic decarboxylase‚ÉŠÖ‚·‚錤‹† ‘æ2•Ò ‚Ä‚ñ‚©‚ñ”]‚Ìglutamic decarboxylaseŠˆ«‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract=The activity of glutamic decarboxylase was measured with the use of cerebral cortices in human idiopathic epilpsy and in experimental epilespy of ep (epileptogenic) mice, of rabbits with local anaphylaxis of the brain and of vitamin B(6) deficiency mice and the folowing results were obtained. 1. While there can be recognized no significant defference in the activity of glutamic decarboxylase in non-focal cerebral cortex of human idiopathic epilepsy from that in the control (non-epileptic brain), the glutamic decarboxylase activity in the focal cortex of the human idiopathic epilepsy is markedly lower than that in the non-focal area. 2. The activity of glutamic decarboxylase in the cerebral cortex of adult ep mice is considerably decreased, but in the immature ep-mice that had not yet experienced convulsion its activity is rather accelerated. 3. The glutamic decarboxylase activity in the cerebral cortex of the rabbit with a local anaphylaxis is not significantly different from that in the normal control rabbit. 4. The activity of glutamic decarboxyase in the brain of vitamin B(6) deficient mice is markedly lower than that in the normal mice brain. en-copyright= kn-copyright= en-aut-name=KondoOsamu en-aut-sei=Kondo en-aut-mei=Osamu kn-aut-name=‹ß“¡® kn-aut-sei=‹ß“¡ kn-aut-mei=® aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æ1iw“àjŠO‰È‹³Žº END start-ver=1.4 cd-journal=joma no-vol=74 cd-vols= no-issue=4-7 article-no= start-page=439 end-page=461 dt-received= dt-revised= dt-accepted= dt-pub-year=1962 dt-pub=19620730 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Experimental Studies on Insulin-Hypoglycemia ......With a Special Reference to Electrophysiological Changes of Central Nervous System...... kn-title=ƒCƒ“ƒVƒ…ƒŠƒ“’ጌ“œó‘Ô‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹†\Žå‚Æ‚µ‚Ä’†•_ŒoŒn‚Ì“d‹C¶—Šw“I•ω»‚ɂ‚¢‚Ä\ en-subtitle= kn-subtitle= en-abstract=With the use of unrestrained and unanesthetized cats implanted with electrodes the author observed normal EEG as well as that of the cats under insulin-hypoglycemia. In addition, observations were carried on the influences of some drugs and electrical stimulation on hypoglycemic EEG. The results are as follows. 1. The low voltage fast waves observable in awaking state change to characteristic sleep spindle of abort 12 c/s as the cat falls into sleeping state, and in deeper sleeping state high voltage slow waves appear in the cortex and various nuclei of subcortex. 2. Hypoglycemic state was classified into lethargic, preconvulsive, convulsive and comatose stages on the basis of characteristic behavior, blood-sugar level and EEG. In the lethargic stage, normal EEG from awaking to deep sleeping state appeared in all leads. In the preconvulsive stage, disturbances of sympathetic nervous system and large slow wave burst were characteristic. In the convulsive stage, spikes and sharp waves were predominant, and furthermore, myoclonic jerk in all muscles and occasionally general convulsion broke out suddenly. In the comatose stage, cats were completely relaxed and 1 cycle/sec or less large slow waves appeared on EEG. In this instance when hypoglycemia was in progress, voltage diminished lower and lower. 3. Arousal effect of excitatory agents and amino acids on insulinhypoglycemia in comparison with that of glucose a) General convulsion Only when general convulsion was induced by electrical stimulation, metrazol and megimide, there could be observed hyperglycemia, awaking patterns on EEG and behavioral wakefulness. In comparison with glucose, however, arousal effect was transient and uncertain. b) Amino acids Sodium glutamate next to glucose had hyperglycemic and arousal action on hypoglycemic cats, but its action was not so fast and long as glucose. The greater the dosage of sodium glutamate administered, the more certain was the effect. Fast administration of large dose, however, is dangerous because it is apt to induce general convulsion. GABA (gamma-amino butyric acid) showed transient hyperglycemic action and arousal patterns on EEG, but no essential change took place in behavior. Although GABOB (gamma-amino beta-hydroxybutyric acid) was administered in the convulsive stage, no definite action was seen. 4. Administration of inhibitory agents to insulin-hypoglycemia a) Nembutal Nembutal administered intravenously in the convulsive stage caused spikes and sharp waves on EEG to disappear and then elicited spindle burst. While myoclonic seizures and convulsions were being suppressed, hypoglycemia continued to progress. In the comatose stage Nembutal was non-effective. b) Chlorpromazine (Cp) Although not so effective as Nembutal, an optimal dose of Cp allows hypoglycemia to proceed gradually. Precaution is necessary with this drug because, when a large dose of Cp is injected rapidly into vein in the convulsive state, it is apt to induce convulsion and then the animal cannot be aroused even by administration of glucose. kn-abstract=A‚¦ž‚Ý“d‹É‚ðŽ{‚µ‚É–«”L‚ð—p‚¢‚Ä,³í”]”g,ƒCƒ“ƒVƒ…ƒŠƒ“’ጌ“œó‘Ô‚¨‚æ‚Ñ‚»‚ê‚ɑ΂·‚é’†•_ŒoŽhŒ, 2, 3‚̃Aƒ~ƒmŽ_‚Æ’†•_Œo—}§•¨Ž¿‚̉e‹¿‚ðŠÏŽ@‚µ‚½.‚»‚ÌŒ‹‰Ê‚ÍŽŸ‚Ì”@‚­‚Å‚ ‚é. 1) ŠoÁŽž‚É”F‚ß‚ç‚ê‚é’áU‹Ð‘¬”g‚Í,”L‚ª–°‚è‚ÉŒX‚­‚Æ“Á’¥“I‚È12c/s‘OŒã‚Ìsleep spindle‚ɕςè,X‚É[‡–°‚ł͔玿‚¨‚æ‚є玿‰º”Šj‚É‚“dˆÊ™”g‚ªoŒ»‚·‚é. 2) ƒCƒ“ƒVƒ…ƒŠƒ“’ጌ“œó‘Ԃ͈ê”Êó‘Ô,ŒŒ“œ’l,”]”g‚ðŠî€‚Æ‚µ‚Ä,šn–°Šú,áz¹‘OŠú,áz¹Šú,¨‡Šú‚Ƃɕª‚¯“¾‚½.šn–°Šú‚ɂͳí”L‚Å”F‚ß‚ç‚ꂽ[‡–°‚ÉŽŠ‚é‚܂ł̂ ‚ç‚ä‚é”]”g‚ª”F‚ß‚ç‚ꂽ.áz¹‘OŠú‚ÍŽ©—¥_ŒoŒn‚Ì—’‚Ƒ噔g‚Ìburst‚ð“Á’¥‚Æ‚µ,áz¹Šú‚Íž™E‰s”g‚ð·‚ñ‚É”F‚ß,ƒ~ƒIƒNƒƒkƒX¹kE‘Sgáz¹‚ª‹N‚é.¨‡Šú‚ɂ͂ ‚ç‚ä‚éŽhŒ‚ɉž‚º‚¸,”]”g‚Å‚Í1c/sˆÈ‰º‚̑噔g‚ð”F‚ß,X‚ɒጌ“œó‘Ԃ𑱂¯‚邯“dˆÊ‚ðŒ¸‚¸‚é. 3) ƒCƒ“ƒVƒ…ƒŠƒ“¨‡‚ɑ΂·‚é’†•_Œo•ŠŠˆÜ‚¨‚æ‚уAƒ~ƒmŽ_‚ÌŠoÁŒø‰Ê‚ð•’“¸“œ‚ðŠî€‚Æ‚µ‚ÄŒŸ“¢‚·‚邯, i) ’†•_ŒoŽhŒ “d‹CŽhŒ,ƒƒgƒ‰ƒ][ƒ‹,ƒƒWƒ}ƒCƒh‚ð—p‚¢‚½‚ª,‘Sg‚Ä‚ñ‚©‚ñ—láz¹”­ì‚ð‹N‚µ‚½Žž‚̂݌Œ“œã¸‚Æ”]”g‚¨‚æ‚шê”Êó‘Ô‚ÌŠoÁ‚ð”F‚ß‚½.•’“¸“œ‚ÉŠr‚ׂ»‚ÌŒø‰Ê‚͈ê‰ß«•sŠmŽÀ‚Å‚ ‚‚½. ii) ƒAƒ~ƒmŽ_ ƒOƒ‹ƒ^ƒ~ƒ“Ž_ƒ\[ƒ_‚Í•’“¸“œ‚ÉŽŸ‚¢‚ÅŒŒ“œã¸ì—p‚ÆŠoÁì—p‚ðŽ‚¿,”]”g‚ðŠ®‘S‚ÉŠoÁƒpƒ^[ƒ“‚É’uŠ·‚µ‚¤‚邪,“œ‚Ù‚Çv‘¬,ŠŽŽ‘±ŽžŠÔ‚ª’·‚­‚È‚¢.‚±‚ÌŒø‰Ê‚̓Oƒ‹ƒ^ƒ~ƒ“Ž_‚Ì“Š—^‚ª‘½‚¢‚Ù‚ÇŠmŽÀ‚Å‚ ‚邪,‚ ‚Ü‚è‘å—Ê‚ð‹}‘¬‚ɓЗ^‚·‚邯ŠëŒ¯‚Å‚ ‚é(‘Sgáz¹‚ð—U”­). GABA‚É‚àˆê‰ß«‚ÌŒŒ“œã¸ì—p‚Æ”]”gã‚ÌŠoÁŒø‰Ê‚ð”F‚ß‚½‚ª,ˆê”Êó‘Ԃɂ͕ω»‚ª‚È‚¢. GABOB‚ðáz¹Šú‚É—p‚¢‚½‚ª,Šm‚©‚È—}§ì—p‚Í”F‚ß‚ç‚ê‚È‚©‚‚½. 4) X‚ɃCƒ“ƒVƒ…ƒŠƒ“’ጌ“œó‘Ô‚É_Œo—}§•¨Ž¿‚ð‰Ád‚µ‚ÄŒŸ“¢‚·‚邯, i) Nembutal áz¹Šú‚ÉNembutal‚ðÃ’‚·‚邯,”]”gã‚Ìž™”gE‰s”g‚ðÁޏ‚¹‚µ‚ß,“Á—L‚È–aŽŒ`‚Ì‚U‹Ð‘¬”gŒQ‚𶂺‚µ‚ß,¹k‹y‚Ñáz¹‚ðŠ®‘S‚É—}§‚µ‚½‚܂ܒጌ“œ‚ðis‚³‚¹‚é. [¨‡Šú‚É‚ÍNembutal‚̉e‹¿‚͂Ȃ¢. ii) Chlorpromazine áz¹‘OŠúˆÈŒã‚É“K“–—Ê‚ÌCp‚ð“K—p‚·‚邯, Nembutal‚قǂł͂Ȃ¢‚ª,’ጌ“œ‚ð©‚Éis‚¹‚µ‚ß‚é.‘å—Ê‚ÌCp‚ð‹}Œƒ‚Éáz¹Šú‚Ì”L‚ÉÃ’‚·‚邯,áz¹‚ð—U”­‚µˆÕ‚­,‚»‚ÌŒã‚É“œ…‚ð•â‹‹‚µ‚Ä‚àŠoÁ‚µ‚É‚­‚¢Ž–‚ª‚ ‚é‚̂ŒˆÓ‚ð—v‚·‚é. en-copyright= kn-copyright= en-aut-name=ShohmoriToshikiyo en-aut-sei=Shohmori en-aut-mei=Toshikiyo kn-aut-name=¯·•q—õ kn-aut-sei=¯· kn-aut-mei=•q—õ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”_Œo‰È END start-ver=1.4 cd-journal=joma no-vol=76 cd-vols= no-issue=1-3 article-no= start-page=41 end-page=46 dt-received= dt-revised= dt-accepted= dt-pub-year=1964 dt-pub=19640330 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=A case report of Epilepsia partialis continua kn-title=Ž‘±«•”•ª«‚Ä‚ñ‚©‚ñ‚̈êÇ—á en-subtitle= kn-subtitle= en-abstract= kn-abstract=We reported a case of epilepsia partialis continua. Movements consist of almost continuous rhythmic jerking which is limited to the right lower limb. Angioma arteriovenosum was seen in the left parietal region on the angiogram of left carotid artery. The clonic jerk of this case was much improved on the anticonvulsants. en-copyright= kn-copyright= en-aut-name=HiramatsuTadashi en-aut-sei=Hiramatsu en-aut-mei=Tadashi kn-aut-name=•½¼’¼ kn-aut-sei=•½¼ kn-aut-mei=’¼ aut-affil-num=1 ORCID= en-aut-name=YokoyamaShigeo en-aut-sei=Yokoyama en-aut-mei=Shigeo kn-aut-name=‰¡ŽR–ζ kn-aut-sei=‰¡ŽR kn-aut-mei=–ζ aut-affil-num=2 ORCID= en-aut-name=IkedaHisao en-aut-sei=Ikeda en-aut-mei=Hisao kn-aut-name=’r“c‹v’j kn-aut-sei=’r“c kn-aut-mei=‹v’j aut-affil-num=3 ORCID= en-aut-name=YamamotoMasatomo en-aut-sei=Yamamoto en-aut-mei=Masatomo kn-aut-name=ŽR–{¹’m kn-aut-sei=ŽR–{ kn-aut-mei=¹’m aut-affil-num=4 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”_Œo¸_ˆãŠw‹³Žº affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”_Œo¸_ˆãŠw‹³Žº affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”_Œo¸_ˆãŠw‹³Žº affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”_Œo¸_ˆãŠw‹³Žº END start-ver=1.4 cd-journal=joma no-vol=81 cd-vols= no-issue=1-2 article-no= start-page=71 end-page=83 dt-received= dt-revised= dt-accepted= dt-pub-year=1969 dt-pub=19690228 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=A case of atypical psychosis characterized by periodic stupor, with marked epileptic factors kn-title=’˜–¾‚ȂĂñ‚©‚ñ«—vˆö‚ðŽ¦‚µC‘}ŠÔ«¨–Àó‘Ô‚ð‚­‚è‚©‚¦‚µ‚½”ñ’èŒ^¸_•a‚Ì1—á en-subtitle= kn-subtitle= en-abstract=A 16-year old girl. It is said that there was a psychotic case in the relatives on the paternal side of the patient. Her hereditary history remains obscure, but her own history is uneventful. A review was made of this case who had episodes of stuporous state six times, and episodes of delutional-hallucinatory state twice since the age of 13. Clinical and EEG observations were carried out from Nov. 1965 to Aug. 1966, and from March 1967 to July 1967 when she was admitted to our clinic. The results are breifly summarized as follows. The stuporous state which presented mutism and akinesia as the principal symptom was difficult to differentiate from the stupor observable in schizophrenia, and it developed in a day or two at the onset, which lasted for about two weeks and then was alleviated. During this period of episodes she showed no noteworthy symptom of disturbed consciousness and she could recall what had happened to her precisely. Her EEG revealed that paroxysmal abnormal waves characterized by spike wave were inhibited during the stuporous state, but in the stage of remission paroxysmal abnormal waves appeared spontaneously and were activated easily by hyperventilation. This stuporous state could be alleviated transiently by the administration of amytal sodium, and also with a large dose of valium it was improved. On the contrary, anti-epileptic agents had no effect at all on the stuporous state. From the characteristic features of the psychotic state, this case could be construed as a type of atypical psychosis, but paroxysmal abnomality on EEG was similar to that of epilepsy, and so this was the case that had clearly shown to stand on the boundary line between atypical psychosis and epilepsy. Therefore, it seemed that epileptic factors of atypical psychosis should be dicided only after long, continuous observations of the case. Some discussion was made on physiological mechanism inducing a stuporous state. Namely, the mechanism that induced a stuporous state seemed to have a close relation to the excitation of system which tried to inhibit the abnormal EEG, and this system was provably the reticular formation system of the midbrain. kn-abstract=Ç—á‚Í13Ë—Žq.гŽÒ‚Ì7e“™‚É‚ ‚½‚镃Œn‚ɸ_•aŽÒ‚ª‚ ‚‚½‚Æ‚¢‚¤‚ªˆâ“`—ð‚ÌÚׂ͕s–¾.Šù‰—ð‚É“Á‹L‚·‚ׂ«‚à‚̂͂Ȃ¢.–{Ç—á‚ɵ—ˆ‚µ‚½‘OŒã7‰ñ‚̨–Àó‘Ô‚Æ,‚»‚Ì‘¼Œ¶Šo–Ï‘z‚Ì•\–ʉ»‚µ‚½,¨–Àó‘ԂƈقȂéó‘Ô‘œ‚ð‚ ‚í‚¹ŠÏŽ@‚µ,”­•a‚æ‚è“ü‰@‚ÉŽŠ‚éŒo‰ß,‹y‚Ñ‘OŒã2‰ñ‚Ì“ü‰@‚ÌŒo‰ß‚ðÚq‚µ‚½.¨–Àó‘Ԃ͂‚悢–³“®–³Œ¾‚ðŽå’›‚Æ‚·‚镪—ô•a«¨–À‚Æ‹æ•ʂ̂‚©‚È‚¢‚à‚Ì‚Å,Žn‚Ü‚è‚Í‹}‚Å1“ú‚ð‹«‚É‚µ‚Ä–K‚ê,2TŠÔ‘OŒã‘±‚«Š°‰ð‚ð‚Ý‚é.‚±‚ÌŠÔ”F‚ނׂ«ˆÓޝáŠQ‚͂Ȃ­,гŽÒ‚ͱׂÈo—ˆŽ––˜‚·‚ׂĂð‘z‹N‚Å‚«‚é.‘OŒã18‰ñ‚Ì”]”g‚É‚æ‚éŒpŽž“IŠÏŽ@‚ðs‚Ȃ‚½Œ‹‰Ê,¨–Àó‘Ô‰º‚Å‚Í,ž™”g‚ð’†S‚Æ‚·‚锭쫈Ùí”g‚Í—}§‚³‚ê,а‰ðŠú‚ɂ͂±‚ꂪoŒ»‚µ‚â‚·‚¢ŒXŒü‚ð”F‚ß‚½.¨–Àó‘Ô‚ÍAmytal sodium‚Å,ˆêŽž“I‚ł͂ ‚邪Œ€“I‚ɉü‘P‚³‚ê, Valium‚Ì‘å—Ê“à•ž‚Å‚à—Õ°‘œ‚ð‰ü‘P‚Å‚«‚½.‚µ‚©‚µR‚Ä‚ñ‚©‚ñÜ‚Í,‚Þ‚µ‚먖Àó‘Ԃɂ͑tŒø‚µ‚È‚©‚‚½.–{ǂ͸_•a‘œ‚©‚ç‚Í”ñ’èŒ^¸_•aŒQ‚Ì1Œ^‚Æ‚µ‚Ă݂ç‚ê‚邪,”­ì”g‚ÌÁ’·‚©‚ç‚Í,‚Ä‚ñ‚©‚ñ‚ɂ݂ç‚ê‚銌©‚Æ“¯ˆê‚ÌŒXŒü‚ð—L‚µ,—¼ŽÒ‚ðŒ‹‚Ô1“_‚ð‘N‚â‚©‚ÉŽ¦‚µ‚½1—á‚Å‚ ‚‚½.”ñ’èŒ^¸_•a‚̂Ăñ‚©‚ñ«—vˆö‚Í‚©‚©‚éÇ—á‚ÌŒpŽž“IŠÏŽ@‚©‚猈’肳‚ê‚é‚ׂ«‚à‚̂ł ‚邯l‚¦‚½.‚»‚Ì‘¼¨–Àó‘Ô‚ÌoŒ»‚Æ,”­ì”g‚ÌÁ’·‚ÉŠÖ‚µ,Žáб‚̶—Šw“I„˜_‚ðŽŽ‚Ý,lŽ@‚ð‰Á‚¦‚½. en-copyright= kn-copyright= en-aut-name=HosokawaK. en-aut-sei=Hosokawa en-aut-mei=K. kn-aut-name=×ì´ kn-aut-sei=×ì kn-aut-mei=´ aut-affil-num=1 ORCID= en-aut-name=NishimuraS. en-aut-sei=Nishimura en-aut-mei=S. kn-aut-name=¼‘ºKŽq kn-aut-sei=¼‘º kn-aut-mei=KŽq aut-affil-num=2 ORCID= en-aut-name=IkedaH. en-aut-sei=Ikeda en-aut-mei=H. kn-aut-name=’r“c‹v’j kn-aut-sei=’r“c kn-aut-mei=‹v’j aut-affil-num=3 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw_Œo¸_ˆãŠw‹³Žº affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw_Œo¸_ˆãŠw‹³Žº affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠw_Œo¸_ˆãŠw‹³Žº END start-ver=1.4 cd-journal=joma no-vol=90 cd-vols= no-issue=9-10 article-no= start-page=1105 end-page=1109 dt-received= dt-revised= dt-accepted= dt-pub-year=1978 dt-pub=19781030 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Two cases of Aleviatin (Diphenylhydantoin) intoxication kn-title=R‚Ä‚ñ‚©‚ñÜiƒAƒŒƒrƒAƒ`ƒ“j‚É‚æ‚镽táŠQ‚Ì2Ç—á en-subtitle= kn-subtitle= en-abstract= kn-abstract=Aleviatin (Diphenylhydantoin) is well known as an excellent antiepileptic drug, especially against grand-mal convulsion. Side reaction of this drug, however, was various and the reports concerning side reaction were many. The authors have reported two patients of Aleviatin intoxication with the complaint of postural disturbance. Some discussions and comments were made on the cases and literatures. Summarizing the symptoms of these side reactions, 1. acute intoxication a. skin manifestations: rash like scarlet fever or urticaria, exfoliative dermatitis, systemic lupus erythematoid eruption, Stevens-Johnson syndrome b. neurological signs: postural disturbance, ataxia, tremor, dysarthria, diplopia, nystagmus, tinnitus, hearing impairment, choreoathetoid movement c. psychological signs: nervousness, excitement, disorientation, insomnia, pseudodementia d. blood manifestation: leucopenia, anemia, leukemoid change e. digestive disorders: thirst, nausea, vomiting, constipation 2. chronic intoxication a. gum hypertrophy b. hypertrichosis c. hyperglycemia en-copyright= kn-copyright= en-aut-name=ShibataShiro en-aut-sei=Shibata en-aut-mei=Shiro kn-aut-name=ŽÄ“cŽl˜Y kn-aut-sei=ŽÄ“c kn-aut-mei=Žl˜Y aut-affil-num=1 ORCID= en-aut-name=TakedaTsuneo en-aut-sei=Takeda en-aut-mei=Tsuneo kn-aut-name=•“cP—Y kn-aut-sei=•“c kn-aut-mei=P—Y aut-affil-num=2 ORCID= en-aut-name=KajiharaMasayuki en-aut-sei=Kajihara en-aut-mei=Masayuki kn-aut-name=ŠŒ´³s kn-aut-sei=ŠŒ´ kn-aut-mei=³s aut-affil-num=3 ORCID= en-aut-name=SaitoRyusuke en-aut-sei=Saito en-aut-mei=Ryusuke kn-aut-name=Ä“¡—´‰î kn-aut-sei=Ä“¡ kn-aut-mei=—´‰î aut-affil-num=4 ORCID= en-aut-name=EndoYoichi en-aut-sei=Endo en-aut-mei=Yoichi kn-aut-name=‰““¡—mˆê kn-aut-sei=‰““¡ kn-aut-mei=—mˆê aut-affil-num=5 ORCID= en-aut-name=OguraYoshio en-aut-sei=Ogura en-aut-mei=Yoshio kn-aut-name=¬‘q‹`˜Y kn-aut-sei=¬‘q kn-aut-mei=‹`˜Y aut-affil-num=6 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”ލ•@ˆôA‰È affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”ލ•@ˆôA‰È affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”ލ•@ˆôA‰È affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”ލ•@ˆôA‰È affil-num=5 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”ލ•@ˆôA‰È affil-num=6 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”ލ•@ˆôA‰È END start-ver=1.4 cd-journal=joma no-vol=87 cd-vols= no-issue=5-6 article-no= start-page=463 end-page=480 dt-received= dt-revised= dt-accepted= dt-pub-year=1975 dt-pub=19750630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Experimental and clinical studies on the catecholamine metabolism 2. Experimental and clinical studies on the catecholamine metabolism in epilepsy. kn-title=ƒJƒeƒR[ƒ‹ƒAƒ~ƒ“‘ãŽÓ‚ÉŠÖ‚·‚éŠî‘b“I‚È‚ç‚тɗհ“IŒ¤‹† ‘æ‡U•Ò ‚Ä‚ñ‚©‚ñ‚̃JƒeƒR[ƒ‹ƒAƒ~ƒ“‘ãŽÓ‚ÉŠÖ‚·‚éŠî‘b“I‚È‚ç‚тɗհ“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=Catecholamine and its metabolites level in cerebrospinal fluid (CSF), serum and urine of the 62 patients with epilepsy (38 males and 24 females, 12 cases of Lennox's syndrome, 48 cases of centrencephalic epilepsy, one case of focal cortical epilepsy and one case of temporal lobe epilepsy) were determined by gas chromatographic method (using an Electron Capture Detector) and fluorometric method. Studies on the epilepsy was performed with a special reference to catecholamine metabolism. As the results, 1) 3, 4-dihydroxyphenylalanine (DOPA) and dopamine in CSF of the epileptics were significantly lower than in the control group. 2) Homovanillic acid (HVA: end-product of dopamine) in CSF of the epileptics was also significantly lower than in the control group. 3) In epileptics tyramine, octopamine and synephrine were detected in CSF. 4) It is speculated in epileptics that the suppression of the pathway from tyrosine to dopamine may act to enhance the side pathway from tyrosine to tyramine followed by octopamine, synephrine and epinephrine. 5) Serum DOPA levels of epileptics being treated with anticonvulsants were abnormal in about half of the cases. 6) Serum MAO activity of epileptics was significantly lower than in the control group. 7) HVA in urine of epileptics tended to increase, but its level was changeable. Based on these clinical studies of epileptics, a penicillin focus was made on the cortex of cats. And effects of the catecholamines to penicillin focus were electroencephalographically examined. 8) Penicillin spikes were strongly inhibited by topical application of dopamine. 9) When octopamine was injected into cisterna magna after the appearance of penicillin spikes, spike frequency increased and abnormal spike discharges were observed. en-copyright= kn-copyright= en-aut-name=KishikawaHidemi en-aut-sei=Kishikawa en-aut-mei=Hidemi kn-aut-name=ŠÝìGŽÀ kn-aut-sei=ŠÝì kn-aut-mei=GŽÀ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•””]‘ãŽÓŒ¤‹†Ž{Ý•a‘Ô¶‰»Šw•”–å END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2009 dt-pub=20090930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=¬Ž™‚Ä‚ñ‚©‚ñгŽÒ‚É‚¨‚¯‚éƒoƒ‹ƒvƒŽ_ŒŒ’†—V—£Œ^”Z“x‚̕ϓ®‰ð͂Ƃ±‚ê‚ÉŠî‚Â­ŽŠ“K“Š—^ÝŒv–@‚ÌŠJ”­ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=UeshimaSatoshi en-aut-sei=Ueshima en-aut-mei=Satoshi kn-aut-name=㓇’q kn-aut-sei=㓇 kn-aut-mei=’q aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol=121 cd-vols= no-issue=3 article-no= start-page=149 end-page=156 dt-received= dt-revised= dt-accepted= dt-pub-year=2009 dt-pub=20091201 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=A CACNB4 mutation showing altered Ca(v)2.1 function in a patient with Dravet syndrome kn-title=Dravet ÇŒóŒQгŽÒ‚É”F‚ß‚ç‚ꂽƒJƒ‹ƒVƒEƒ€ƒ`ƒƒƒlƒ‹@‹@”\ˆÙí‚ðˆø‚«‹N‚±‚· CACNB4 ˆâ“`Žq•ψ٠en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=OhmoriIori en-aut-sei=Ohmori en-aut-mei=Iori kn-aut-name=‘åŽçˆÉD kn-aut-sei=‘åŽç kn-aut-mei=ˆÉD aut-affil-num=1 ORCID= en-aut-name=OuchidaMamoru en-aut-sei=Ouchida en-aut-mei=Mamoru kn-aut-name=‘å“à“cŽç kn-aut-sei=‘å“à“c kn-aut-mei=Žç aut-affil-num=2 ORCID= en-aut-name=MimakiNobuyoshi en-aut-sei=Mimaki en-aut-mei=Nobuyoshi kn-aut-name=Œä–qM‹` kn-aut-sei=Œä–q kn-aut-mei=M‹` aut-affil-num=3 ORCID= en-aut-name=NishikiTeiichi en-aut-sei=Nishiki en-aut-mei=Teiichi kn-aut-name=¼–Ø’õˆê kn-aut-sei=¼–Ø kn-aut-mei=’õˆê aut-affil-num=4 ORCID= en-aut-name=TomizawaKazuhito en-aut-sei=Tomizawa en-aut-mei=Kazuhito kn-aut-name=•xàVˆêm kn-aut-sei=•xàV kn-aut-mei=ˆêm aut-affil-num=5 ORCID= en-aut-name=MatsuiHideki en-aut-sei=Matsui en-aut-mei=Hideki kn-aut-name=¼ˆäGŽ÷ kn-aut-sei=¼ˆä kn-aut-mei=GŽ÷ aut-affil-num=6 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@×–E¶—Šw affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@•ªŽqˆâ“`Šw affil-num=3 en-affil= kn-affil=‘q•~¬l•aƒZƒ“ƒ^[@¬Ž™‰È affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@×–E¶—Šw affil-num=5 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@×–E¶—Šw affil-num=6 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È@×–E¶—Šw en-keyword=‚Ä‚ñ‚©‚ñ kn-keyword=‚Ä‚ñ‚©‚ñ en-keyword=Dravet ÇŒóŒQ kn-keyword=Dravet ÇŒóŒQ en-keyword=CACNB4ˆâ“`Žq kn-keyword=CACNB4ˆâ“`Žq en-keyword=SCN1A ˆâ“`Žq kn-keyword=SCN1A ˆâ“`Žq END start-ver=1.4 cd-journal=joma no-vol=91 cd-vols= no-issue=11-12 article-no= start-page=1649 end-page=1664 dt-received= dt-revised= dt-accepted= dt-pub-year=1979 dt-pub=19791230 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=The therapeutic prognosis of patients with epilepsy during long-term follow-up kn-title=‚Ä‚ñ‚©‚ñ‚ÌŽ¡—×\Œã en-subtitle= kn-subtitle= en-abstract= kn-abstract=The purpose of this study was to investigate the therapeutic prognosis of adult patients with epilepsy during long-term follow-up. The subjects of the present study were 286 epileptic patients seen by the author at the Department of Neuro-Psychiatry, Okayama University Hospital and Tsuyama Sekizen Hospital. All patients had been on therapy for more than five years. The age, onset of seizure and period of treatment of these patients were in order 35.1}11.5 y.o. (mean}SD), 15.9}10.2 y.o. (mean}SD), and 12.4}4.9 years (mean}SD). As classified by the criteria of the International League Against Epilepsy, the present study consisted of cases with; Partial Seizures 167 (58.4%) Primary Ceneralized Seizures 115 (40.2%) Secondary Generalized Seizures 4 (1.4%) The clinical course over the past three years was used as the period to determine the therapeutic prognosis. To describe the therapeutic prognosis, four categories were created taking types and frequency of seizures into consideration; i.e., "seizure-free", "mild", "moderate", and "severe". Results were: 1) "Seizure-free" 99 (34.6%), "mild" 91 (31.8%), "moderate" 54 (18.9%), and "severe" 42(14.7%). 2) In 187 patients, seizures were not abolished. In 89 cases (47.6%) change of seizure type occurred under treatment. The facts elucidated were; a) Partial seizures were resistent even to continued therapeutic efforts. b) Tonic-clonic general convulsions in primary generalized seizures and partial seizure with secondarily generalized responded well to therapy, disappearing promptly and permanently. c) "Abortive-minor seizure" occurred under treatment. d) The change from primary generalized seizures to partial seizures was seen in several cases. 3) Multidimensional comparisons regarding factors which may influence therapeutic prognosis were conducted. In "seizure-free" and "severe" cases, factors which showed statistically significant differences were as follows; In "seizure-free" cases, the first of each following pair showed the better prognosis; a) Seizure types: Primary generalized seizures and partial seizures. b) Etiology: "hereditary" and "residual". c) Etiology: "cryptogenic" and "residual". d) Duration prior to therapy: "within 3 years" and "over 3 years". In "severe" cases, the first of each following pair showed the poorer prognosis; a) Seizure types: partial seizures and primary generalized seizures. b) Etiology: "residual" and "cryptogenic". c) Sexual differences: women and men. 4) Psychiatric problems were observed in 143 cases (50.0%). These patients had a poor prognosis. Patients with partial seizures had more psychiatric problems than patients with primary generalized seizures. en-copyright= kn-copyright= en-aut-name=KugohToshiaki en-aut-sei=Kugoh en-aut-mei=Toshiaki kn-aut-name=‹v‹½•q–¾ kn-aut-sei=‹v‹½ kn-aut-mei=•q–¾ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”_Œo¸_ˆãŠw‹³Žº en-keyword=Epilepsy kn-keyword=Epilepsy en-keyword=Prognosis kn-keyword=Prognosis en-keyword=Change of seizure types kn-keyword=Change of seizure types en-keyword=International kn-keyword=International en-keyword=Classification kn-keyword=Classification END start-ver=1.4 cd-journal=joma no-vol=93 cd-vols= no-issue=11-12 article-no= start-page=1137 end-page=1150 dt-received= dt-revised= dt-accepted= dt-pub-year=1981 dt-pub=19811230 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=CBA mouse convulsion and brain monoamine kn-title=CBAƒ}ƒEƒX‚Ìáz¹‚Æ”]“àƒ‚ƒmƒAƒ~ƒ“‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=Convulsions were induced in 80% of CBA mice by throwing stimulation six from eight weeks after birth, and continued for more than one year. The procedure for causing a CBA mouse convulsion was as follows: the mouse was rolled over suddenly by throwing stimulation and set in tonic flexion. After a few seconds of clonic convulsion, tonic extension followed, and opisthotonus was observed in this stage. After a convulsion, the mouse rose, seemed stunned for a few seconds, then recovered to a normal state. This convulsive process took about 10-15 seconds for the whole procedure. Urinary incontinence was observed. Bilateral sporadic spikes of about 100-150ƒÊV were induced in the resting stage of stimulated CBA mice, but the EEG was not abnormal in normal untreated mice. Dopamine (DA) in the cortex and brainstem of the CBA mouse at the pre-convulsive stage was significantly decreased compared with the resting stage, and these changes recovered during the convulsion stage. DA in the cerebellum was also significantly decreased one hour after convulsion. Norepinephrine (NE) of CBA cortex was significantly decreased before, during, and one hour after, a convulsion, compared with the resting stage. 5-Hydroxytryptamine (5-HT) in the CBA brainstem was significantly decreased compared with the resting stage, and this change recovered to the normal level one hour after a convulsion. DA and 5 HT of the cortex of CBA mice, which convulsions had induced for more than one year, were significantly decreased compared with untreated CBA mice of the same age. There was no difference in the monoamines of CBA mouse brain between females and males. en-copyright= kn-copyright= en-aut-name=TsuoMichio en-aut-sei=Tsuo en-aut-mei=Michio kn-aut-name=’Ôö“¹—Y kn-aut-sei=’Ôö kn-aut-mei=“¹—Y aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•””]‘ãŽÓŒ¤‹†Ž{Ý‹@”\¶‰»Šw•”–å en-keyword=CBAƒ}ƒEƒX (CBA mouse) kn-keyword=CBAƒ}ƒEƒX (CBA mouse) en-keyword=áz¹ (convulsion) kn-keyword=áz¹ (convulsion) en-keyword=‚Ä‚ñ‚©‚ñ—lƒXƒpƒCƒN (epileptic discharges) kn-keyword=‚Ä‚ñ‚©‚ñ—lƒXƒpƒCƒN (epileptic discharges) en-keyword=”]“àƒ‚ƒmƒAƒ~ƒ“ (brain monoamine) kn-keyword=”]“àƒ‚ƒmƒAƒ~ƒ“ (brain monoamine) END start-ver=1.4 cd-journal=joma no-vol=93 cd-vols= no-issue=11-12 article-no= start-page=1105 end-page=1119 dt-received= dt-revised= dt-accepted= dt-pub-year=1981 dt-pub=19811230 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=ƒ¿-Guanidinoglutaric acid and other guanidino compounds in a cobalt epileptogenic focus of cat cerebral cortex kn-title=ƒRƒoƒ‹ƒg‚Ä‚ñ‚©‚ñŒ¹«Å“_‘gD‚̃¿-guanidinoglutaric acid‹y‚Ñ‚»‚Ì‘¼‚Ìguanidino‰»‡•¨‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=An epileptogenic cortical focus was induced by the topical application of cobalt powder to the sensori-motor cortex, then guanidino compounds in the cobalt focus were analysed by HPLC. An extraordinally high peak was observed in the epileptogenic focus 24 hours after the cobalt application. ƒ¿-Guanidinoglutaric acid (GGA), which is synthesized from glutamic acid and S-methylisothiourea sulfate, was confirmed by GC/MS as a dimethylpyrimidyl derivative of GGA. An unknown substance was isolated from the cobalt focus and identified as GGA by the same GC/MS technique as in the case of an authentic sample. GGA was present in the normal cat cortex in amounts of 1n mol/g. GGA increased after cobalt application, and reached a maximum after 24 hours. The abnormal GGA recovered to the normal level about 40days after the application by which time the cobalt focus had disappeared. Other guanidino compounds, that is taurocyamine, guanidinosuccinic acid, guanidinoacetic acid, ƒÀ-guanidinopropionic acid, creatinine, ƒÁ-guanidinobutyric acid, arginine, and methylguanidine, except for guanidine tended to decrease in the cobalt focus. Taurocyamine and ƒ¿-guanidinobutyric acid were still decreased 40 days after the cobalt application. Spike and wave complex was induced after topical application of 0.2M GGA to the sensori-motor cortex, and a burst continued for one hour. en-copyright= kn-copyright= en-aut-name=AkagiMasayuki en-aut-sei=Akagi en-aut-mei=Masayuki kn-aut-name=ԖسK kn-aut-sei=Ô–Ø kn-aut-mei=³K aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•””]‘ãŽÓŒ¤‹†Ž{Ý‹@”\¶‰»Šw•”–å en-keyword=ƒRƒoƒ‹ƒgÅ“_ (cobalt focus) kn-keyword=ƒRƒoƒ‹ƒgÅ“_ (cobalt focus) en-keyword=ƒ¿-guanidinoglutaric acid kn-keyword=ƒ¿-guanidinoglutaric acid en-keyword=guanidino‰»‡•¨ (guanidino compounds) kn-keyword=guanidino‰»‡•¨ (guanidino compounds) en-keyword=EEG kn-keyword=EEG en-keyword=”­ì‹@˜ (seizure mechanism) kn-keyword=”­ì‹@˜ (seizure mechanism) END start-ver=1.4 cd-journal=joma no-vol=94 cd-vols= no-issue=1-2 article-no= start-page=87 end-page=102 dt-received= dt-revised= dt-accepted= dt-pub-year=1982 dt-pub=19820228 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=The nucleus accumbens septi and the limbic seizure: Studied by kindling preparation. kn-title=‘¤¿Šj‚ƕӉŒn”­ì\”R‚¦ã‚ª‚茻ۂð—p‚¢‚½Œ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=An antagonistic relationship between epilepsy and psychosis has been claimed. On the other hand, abnormality of the N. accumbens is thought to be involved in schizophrenia and temporal lobe epilepsy. In order to examine the role of the N. accumbens in limbic seizure and psychosis, the following were studied: 1. Amygdaloid kindling and the functional change of the N. accumbens, 2. Accumbens kindling, 3. Functional change of limbic nuclei following the accumbens kindling, and 4. The effects of lesioning of the N. accumbens on the amygdaloid kindling. The results were as follows: 1. The amygdaloid kindling induced epileptic focus and positive transfer into the N. accumbens. 2. The kindling phenomenon was confirmed positive by repeated stimulation of the N. accumbens. Clinicoelectrographic seizure development during the N. accumbens kindling resembled that of amygdaloid kindling. The mean minimum intensities to induce afterdischarge and kindling rate were 620ƒÊA and 23days, respectively. 3. Positive transfer was found in the N. amygdala and hippocampus following the accumbens kindling. 4. Lesioning of the N. accumbens had no effect on amygdaloid seizure development, but lowered the threshold intensity to induce amygdaloid afterdischarge after kindling. It was concluded that the N. accumbens and the N. amygdala formed epileptic hyperexcitability reciprocally and that the N. accumbens had an inhibitory effect on the limbic seizure, but no effect on the developed amygdaloid kindling. en-copyright= kn-copyright= en-aut-name=YamashitaMotoshi en-aut-sei=Yamashita en-aut-mei=Motoshi kn-aut-name=ŽR‰ºŒ³Ži kn-aut-sei=ŽR‰º kn-aut-mei=Œ³Ži aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”_Œo¸_ˆãŠw‹³Žº en-keyword=‘¤¿Šj kn-keyword=‘¤¿Šj en-keyword=”R‚¦ã‚ª‚èŒ»Û kn-keyword=”R‚¦ã‚ª‚èŒ»Û en-keyword=•Ó‰Œn”­ì kn-keyword=•Ó‰Œn”­ì en-keyword=’†”]•Ó‰ƒhƒpƒ~ƒ“Œn kn-keyword=’†”]•Ó‰ƒhƒpƒ~ƒ“Œn en-keyword=‘¤“ª—t‚Ä‚ñ‚©‚ñ kn-keyword=‘¤“ª—t‚Ä‚ñ‚©‚ñ END start-ver=1.4 cd-journal=joma no-vol=95 cd-vols= no-issue=3-4 article-no= start-page=271 end-page=282 dt-received= dt-revised= dt-accepted= dt-pub-year=1983 dt-pub=19830430 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Brain active oxygen, free radicals, lipid peroxide and the redox state of glutathione in the Fe(3+) induced epileptic focus of the rat kn-title=“SƒCƒIƒ“‚Ä‚ñ‚©‚ñŒ¹«Å“_‘gD‚̃tƒŠ[ƒ‰ƒWƒJƒ‹”½‰ž‚Æ”­ì”­Œ»‹@\‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=Epileptic discharges were induced 15 minutes after 0.1M FeCl(3) was injected into the rat sensory motor cortex and continued for 6 months after the injection. In order to study the Fe(3+) induced seizure mechanism, Fe(3+) bound methemoglobin, free radicals, active oxygen, malondialdehyde and reduced and oxidized glutathione were measured in the foci of rats after the FeCl(3) injection. It was found that Fe(3+) induced a significant increase in Fe(3+) bound methemoglobin, active oxygen and malondialdehyde and accelerated the glutathione redox reaction 5 minutes after the injection. Fe(3+) was thought to induce lipid peroxidation by free radical reaction and thus produce the peileptic focus. en-copyright= kn-copyright= en-aut-name=KhochiHiroyoshi en-aut-sei=Khochi en-aut-mei=Hiroyoshi kn-aut-name=‚’mGŠì kn-aut-sei=‚’m kn-aut-mei=GŠì aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•””]‘ãŽÓŒ¤‹†Ž{Ý‹@”\¶‰»Šw•”–å en-keyword=“SƒCƒIƒ“‚Ä‚ñ‚©‚ñ kn-keyword=“SƒCƒIƒ“‚Ä‚ñ‚©‚ñ en-keyword=ƒtƒŠ[ƒ‰ƒWƒJƒ‹ kn-keyword=ƒtƒŠ[ƒ‰ƒWƒJƒ‹ en-keyword=Šˆ«Ž_‘f kn-keyword=Šˆ«Ž_‘f en-keyword=‰ßŽ_‰»Ž‰Ž¿ kn-keyword=‰ßŽ_‰»Ž‰Ž¿ en-keyword=ƒOƒ‹ƒ^ƒ`ƒIƒ“ kn-keyword=ƒOƒ‹ƒ^ƒ`ƒIƒ“ END start-ver=1.4 cd-journal=joma no-vol=96 cd-vols= no-issue=3-4 article-no= start-page=313 end-page=325 dt-received= dt-revised= dt-accepted= dt-pub-year=1984 dt-pub=19840430 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Analysis of guanidino compounds in human cerebrospinal fluid. -Guanidinoethanesulfonic acid is observed in some epileptics- kn-title=ƒqƒg‘‰t’†‚̃OƒAƒjƒWƒm‰»‡•¨‚ÉŠÖ‚·‚錤‹† \“Á‚ɂĂñ‚©‚ñгŽÒ‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract=Guanidino compounds in cerebrospinal fluid (CSF) of nonneurological and epileptic patients were investigated. After separating using high performance liquid chromatography, and reacting with phenanthrenequinone, the compounds were analyzed fluorometrically. Arginine (Arg), creatinine (CRN) and homoarginine (HArg) were found in all subjects. Trace amounts of guanidinosuccinic acid (GSA) and guanidinoacetic acid (GAA) were detected in some subjects regardless of disease state. Positive correlations were noted in females between Arg and CRN levels and age. Serum Arg and HArg levels were related to in urine concentrations, but there was no association between CSF guanidino compound levels and serum levels. Guanidinoethanesulfonic acid (GES) was detected in the CSF of some epileptic patients. This was confirmed by high voltage paper electrophoresis. This finding suggests that GES may relate to epileptic seizure mechanism. en-copyright= kn-copyright= en-aut-name=FujimotoNoboru en-aut-sei=Fujimoto en-aut-mei=Noboru kn-aut-name=“¡–{¸ kn-aut-sei=“¡–{ kn-aut-mei=¸ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•””]‘ãŽÓŒ¤‹†Ž{Ý‹@”\¶‰»Šw•”–å en-keyword=ƒOƒAƒjƒWƒm‰»‡•¨ kn-keyword=ƒOƒAƒjƒWƒm‰»‡•¨ en-keyword=‘‰t kn-keyword=‘‰t en-keyword=‚Ä‚ñ‚©‚ñ kn-keyword=‚Ä‚ñ‚©‚ñ en-keyword=ƒOƒAƒjƒWƒmƒGƒ^ƒ“ƒXƒ‹ƒzƒ“Ž_ kn-keyword=ƒOƒAƒjƒWƒmƒGƒ^ƒ“ƒXƒ‹ƒzƒ“Ž_ END start-ver=1.4 cd-journal=joma no-vol=97 cd-vols= no-issue=9-10 article-no= start-page=855 end-page=870 dt-received= dt-revised= dt-accepted= dt-pub-year=1985 dt-pub=19851030 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=The effects of bilateral ventral hippocampal lesions on amygdaloid kindling in cats kn-title=—¼‘¤• ‘¤ŠC”n”j‰ó‚É‚æ‚éG“ŠjƒLƒ“ƒhƒŠƒ“ƒO‚ւ̉e‹¿ en-subtitle= kn-subtitle= en-abstract= kn-abstract=The clinical relevance of Ammon's horn sclerosis in epilepsy has not been fully ellucidated. This study was designed to examine the effects of bilateral ventral hippocampal lesions (Ammon's horn + dentate gyrus) on the minimal electroconvulsive threshold (ECT) intensity, kindling rates and transference phenomenon in cats kindled from the amygdala (AM). Ten adult cats were used. In the first experiment, lesions were made electrolytically in the bilateral hippocampi after completion of the primary site (PS) kindling from the left AM. Subsequently, the right AM (secondary site: SS) was kindled. In the second experiment, the hippocampal lesion was made prior to the PS-kindling which was followed by the SS-kindling. In the first experiment, the ECT intensity was unchanged by the hippocampal lesions after PS-kindling. The seizure pattern and EEG pattern in the generalized convultion were changed to show an asymmetrical, asynchronous pattern by the lesions. Facilitation of SS-kindling following the PS-kindling (positive transfer) was diminished by the lesions. In the second experiment, the formation of hippocampal lesions prior to the kindling retarded the PS kindling rates slightly. The seizure pattern and EEG pattern of the generalized convulsion was asymmetrical and asynchronous. In addition, positive transfer from PS to SS was blocked by the lesions. These results indicate that the ventral hippocampal formation and hippocampal commissure may be critical brain sites for the establishment of the transference phenomenon that reflects secondary epileptogenic changes in the brain. en-copyright= kn-copyright= en-aut-name=NakatsuTakeshi en-aut-sei=Nakatsu en-aut-mei=Takeshi kn-aut-name=’†’ÕŽu kn-aut-sei=’†’à kn-aut-mei=•Žu aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”_Œo¸_ˆãŠw‹³Žº en-keyword=G“ŠjƒLƒ“ƒhƒŠƒ“ƒO kn-keyword=G“ŠjƒLƒ“ƒhƒŠƒ“ƒO en-keyword=• ‘¤ŠC”n”j‰ó kn-keyword=• ‘¤ŠC”n”j‰ó en-keyword=“]ˆÚŒ»Û kn-keyword=“]ˆÚŒ»Û en-keyword=“ñŽŸ‚Ä‚ñ‚©‚ñŒ´« kn-keyword=“ñŽŸ‚Ä‚ñ‚©‚ñŒ´« END start-ver=1.4 cd-journal=joma no-vol=97 cd-vols= no-issue=1-2 article-no= start-page=149 end-page=160 dt-received= dt-revised= dt-accepted= dt-pub-year=1985 dt-pub=19850225 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Electroencephalographic studies of iron-induced focal epilepsy kn-title=“S‰–—U“±Å“_«‚Ä‚ñ‚©‚ñ‚Ì”]”gŠw“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=Electrocorticograms (ECoGs) and somatosensory evoked potentials (SEPs) were recorded, and convulsion thresholds were determined in rats in which FeCl(2) solution was injected into the unilateral sensorimotor cortex. Isolated spikes appeared immediately after the injection of FeCl(2) solution in ECoGs of the cortex near the injection site and the contralateral homotopic cortex. The injection of FeCl(2) solution produced different electrocorticographic features in which the frequency of isolated spikes was dominant on the side ipsilateral or contralateral to the injection site or nearly equal on the two sides. The spike frequency increased up to 30 to 50 days after the injection, and then was almost constant in most of the rats up to 90 days after the injection. In rats showing nearly equal spike activity on the two sides, there was a tendency for the spike frequency to decrease gradually after 30 to 50 days. Most of the spike and slow wave complexes appeared bilaterally one month or more after the injection in rats in which the isolated spike activity was dominant on the side ipsilateral to the injection site or nearly equal on the two sides. The proportion of rats showing spike and slow wave complexes increased steeply until three months after the injection, and reached 36% of all the FeCl(2) solution-injected rats six months after the injection. In ECoGs of these rats, isolated spikes were also detected. In rats showing dominant spike activity on either side of the cortex, most of spikes appeared unilaterally, while in rats showing nearly equal spike activity on the two sides and those showing spike and slow wave complexes, the frequency of almost synchronous spikes on both sides was higher than that of unilateral spikes. In rats showing dominant spike activity on the side contralateral to the injection site, SEPs recorded at the cortex near the injection site were devoid of the initial positive deflection and were monophasic. They were biphasic in other FeCl(2) solution-injected rats. In rats showing only isolated spikes, abnormal behavior was seldom observed, and convulsion thresholds were lowered. In most of the rats showing spike and slow wave complexes, head nodding was observed. The induction and development of epileptic focus by FeCl(2) solution are discussed. en-copyright= kn-copyright= en-aut-name=NishidaNobuyoshi en-aut-sei=Nishida en-aut-mei=Nobuyoshi kn-aut-name=¼“c‹X‰Â kn-aut-sei=¼“c kn-aut-mei=‹X‰Â aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æˆê¶—Šw‹³Žº en-keyword=“S‰–—U“±‚Ä‚ñ‚©‚ñ kn-keyword=“S‰–—U“±‚Ä‚ñ‚©‚ñ en-keyword=ƒ‰ƒbƒg‘å”]”玿 kn-keyword=ƒ‰ƒbƒg‘å”]”玿 en-keyword=”]”g kn-keyword=”]”g en-keyword=‘Ì«Š´Šo—U”­“dˆÊ kn-keyword=‘Ì«Š´Šo—U”­“dˆÊ en-keyword=‚¯‚¢‚ê‚ñ kn-keyword=‚¯‚¢‚ê‚ñ en-keyword=臒l kn-keyword=臒l END start-ver=1.4 cd-journal=joma no-vol=97 cd-vols= no-issue=1-2 article-no= start-page=127 end-page=147 dt-received= dt-revised= dt-accepted= dt-pub-year=1985 dt-pub=19850225 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Studies on the cyclic AMP-generating system of cerebral cortex with iron-induced epileptic focus kn-title=“S‰–—U“±‚Ä‚ñ‚©‚ñ«‘å”]”玿‚̃TƒCƒNƒŠƒbƒNAMP‡¬Œn‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=The cyclic AMP contents of cortical slices after incubation with or without agents such as norepinephrine were determined in four areas of rat cerebral cortex in which FeCl(2) solution was injected into the unilateral sensorimotor cortex to induce an epileptic focus. Norepinephrine, isoproterenol and phenylephrine elevated the cyclic AMP levels of cortical slices 4- to 7-fold, 2- to 4-fold and 1.5- to 3-fold, respectively. The elicitation of cyclic AMP accumulation by norepinephrine was inhibited by 30 to 60% with phentolamine and 65 to 80% with propranolol. 8-Phenyltheophylline almost completely inhibited the elicitation of cyclic AMP accumulation by a norepinephrine-propranolol combination but not by a norepinephrine-phentolamine combination. In anterior cortical areas of rats in which the appearance of isolated spikes in electrocorticograms was dominant either ipsilaterally or contralaterally to the injection site 8 to 10 days after the injection of FeCl(2) solution, the elevated levels of cyclic AMP elicited by norepinephrine, isoproterenol and a norepinephrine-phentolamine combination were higher on the side of dominant spike activity than on the other. In anterior cortical areas of rats showing dominant spike activity on either side of the cortex 31 to 60 days after the injection, the elevated levels of cyclic AMP elicited by norepinephrine and phenylephrine were lower on the dominant side than on the other. In anterior cortical areas of rats showing nearly equal spike activity on the two sides 31 to 60 days after the injection, the elevated levels of cyclic AMP elicited by norepinephrine, isoproterenol and a norepinephrine-phentolamine combination were higher on the side ipsilateral to the injection site than on the other. In these rats, a similar regional difference in the norepinephrine-elicited accumulation of cyclic AMP was detected 19 to 21 days after the injection. In anterior and posterior cortical areas of rats in which the appearance of spike and slow wave complexes as well as isolated spikes were detected 31 to 60 days after the injection, the elevated levels of cyclic AMP elicited by norepinephrine, isoproterenol, phenylephrine and combinations of norepinephrine and phentolamine or propranolol were higher on the side ipsilateral to the injection site than on the other. The tendency for the norepinephrine-elicited accumulation of cyclic AMP to be related to the epileptic discharge patterns in rats 61 to 90 days after the injection was similar to that in rats 31 to 60 days after the injection. The regional differences in cyclic AMP contents of incubated cortical slices are discussed with regard to the neurochemical process of iron-induced epilepsy. en-copyright= kn-copyright= en-aut-name=YasuharaHiromichi en-aut-sei=Yasuhara en-aut-mei=Hiromichi kn-aut-name=ˆÀŒ´O’Ê kn-aut-sei=ˆÀŒ´ kn-aut-mei=O’Ê aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æˆê¶—Šw‹³Žº en-keyword=ƒTƒCƒNƒŠƒbƒNAMP kn-keyword=ƒTƒCƒNƒŠƒbƒNAMP en-keyword=ƒmƒ‹ƒGƒsƒlƒtƒŠƒ“ kn-keyword=ƒmƒ‹ƒGƒsƒlƒtƒŠƒ“ en-keyword=ƒ‰ƒbƒg‘å”]”玿 kn-keyword=ƒ‰ƒbƒg‘å”]”玿 en-keyword=ؕРkn-keyword=ؕРen-keyword=“S‰–—U“±‚Ä‚ñ‚©‚ñ kn-keyword=“S‰–—U“±‚Ä‚ñ‚©‚ñ END start-ver=1.4 cd-journal=joma no-vol=99 cd-vols= no-issue=7-8 article-no= start-page=787 end-page=806 dt-received= dt-revised= dt-accepted= dt-pub-year=1987 dt-pub=19870830 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Guanidino compounds in iron-induced epileptogenic foci of rats kn-title=“S‰–—U“±‚Ä‚ñ‚©‚ñŒ´«Å“_‘gD‚É‚¨‚¯‚éƒOƒAƒjƒWƒm‰»‡•¨‚̕ϓ®‚ÉŠÖ‚·‚錤‹† \ “Á‚Ƀ‰ƒWƒJƒ‹”½‰ž‚É‚æ‚éƒOƒAƒjƒWƒm‰»‡•¨‚̶¬‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract=Changes in the levels of guanidino compounds in the cortex, hippocampus, striatum, hypothalamus, midbrain, pons and medulla oblongata and cerebellum were analyzed by high performance liquid chromatography after an injection of ferric chloride into the sensory motor cortex of SD rats. Levels of guanidinoacetic acid (GAA) and methylguanidine (MG) changed greatly 15 and 30 min after the injection, but recovered to normal levels 24 to 48 hours after the injection. GAA and MG increased two or three times the normal level 2 months after the injection, at which time iron-induced epileptogenic foci were formed. Levels of other guanidino compounds, i.e., N-acetylarginine, guanidinoacetic acid, arginine (Arg), homoarginine and creatinine (CRN) also changed, though the extent of the changes was not as marked as with GAA and MG. Rapidly increased generation of hydroxyl radical and peroxide intermediate radical(s) was observed by electron spin resonance analysis after addition of ferric chloride and hydrogen peroxide to rat brain homogenate. Levels of MG and GAA also increased. A significant relationship between the generation of hydroxyl radical and the formation of MG was recognized. The formation of MG in the system was dependent on the concentration of CRN but independent of the concentration of Arg and GAA. These results suggest that MG formed from CRN may act on neurones after iron injection into the rat brain, thus forming epileptogenic feci. en-copyright= kn-copyright= en-aut-name=FukushimaMasato en-aut-sei=Fukushima en-aut-mei=Masato kn-aut-name=•Ÿ“‡³“o kn-aut-sei=•Ÿ“‡ kn-aut-mei=³“o aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•””]‘ãŽÓŒ¤‹†Ž{Ý‹@”\¶‰»Šw•”–å en-keyword=“S‰–—U“±‚Ä‚ñ‚©‚ñŒ´«Å“_ kn-keyword=“S‰–—U“±‚Ä‚ñ‚©‚ñŒ´«Å“_ en-keyword=ƒOƒAƒjƒWƒm‰»‡•¨ kn-keyword=ƒOƒAƒjƒWƒm‰»‡•¨ en-keyword=ƒ‰ƒbƒg kn-keyword=ƒ‰ƒbƒg en-keyword=ƒ‰ƒWƒJƒ‹”½‰ž kn-keyword=ƒ‰ƒWƒJƒ‹”½‰ž en-keyword=ƒƒ`ƒ‹ƒOƒAƒjƒWƒ“ kn-keyword=ƒƒ`ƒ‹ƒOƒAƒjƒWƒ“ END start-ver=1.4 cd-journal=joma no-vol=8 cd-vols= no-issue=1 article-no= start-page=31 end-page=35 dt-received= dt-revised= dt-accepted= dt-pub-year=1997 dt-pub=19970910 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Correlative study of hippocampal atrophy assessed by MRI and clinical features in temporal lobe epilepsy. kn-title=‘¤“ª—t‚Ä‚ñ‚©‚ñ‚ÌŠC”nˆÞk‚Æ—Õ°‘œ‚ÌŒŸ“¢ \MRI‚ð—p‚¢‚½ŠC”nˆÞk‚̊ȈՕ]‰¿\ en-subtitle= kn-subtitle= en-abstract=We studied hippocampal atrophy in 39 patients with temporal lobe epilepsy using MRI. The ratio (a) of the width of the hippocampus on the atrophic side to that on the contralateral side was measured in coronal sections of the short SE in MRI. According to this ratio, the patients were divided into three groups : 11 with hippocampal atrophy (a<0.8), 13 with borderline atrophy (0.8…a…0.9), and 15 with no hippocampal atrophy (a†0.8). In the patients of the group with hippocampal atrophy, the clinical history of epilepsy tended to be long, and the site of hippocampal atrophy was consistent with that of interictal spike foci on the electroencephalogram in 9 out of 11 patients. However, there was no difference between the three groups, with regard to age at onset, age when MRI was conducted, frequency of seizures, generalized seizures, the types and doses of antiepileptic drugs used, history of neonatal asphyxia, intelligence and epilpetic psychosis. These results suggest that hippocampal atrophy in temporal lobe epilepsy may be related to repetition of epileptic dischargges in a localized part of the brain. kn-abstract=‘¤“ª—t‚Ä‚ñ‚©‚ñгŽÒ39—á‚ÌŠC”nˆÞk‚ðMRI‚ð—p‚¢‚Ä•]‰¿‚µ,—Õ°‘œ‚Ƃ̊֘A‚ðŒŸ“¢‚µ‚½¡MRI‚ÌŠ¥ó’fshort SE‘œ‚ÅŠC”n‚Ì•‚ðŒv‘ª‚µ,ˆÞk‘¤ŠC”n‚Ì‘º‘¤ŠC”n‚ɑ΂·‚é”ä(a)‚ð‹‚ß,ŠC”nˆÞk(+)ŒQ;a<0.8,11—á,‹«ŠEŒQ;0.8…a<0.9,13—á,ŠC”nˆÞk(-)ŒQ;a†0.9,15—á‚Ì3ŒQ‚É•ª‚¯‚½¡ŠC”nˆÞk(+)ŒQ‚Åœë•aŠúŠÔ‚ª’·‚¢ŒXŒü‚ª‚ ‚Á‚½¡‚Ü‚½,”­ìŠÔŸ[Šú”]”g‚ÌÅ“_‘¤‚ÍŠC”nˆÏk(+)ŒQ‚Ì11—á’†9—á‚ňÞk‘¤‚ƈê’v‚µ‚½B‚µ‚©‚µ,”­•a”N—î,MRIŽB‰eŽž”N—î,”­ì•p“x,‘S”ʉ»”­ì‚Ì—L–³,R‚Ä‚ñ‚©‚ñ–ò‘•ž—p—Ê,’m”\áŠQ,¸_Çó,¶‰ºŽž‰¼Ž€‚Ì—L–³‚ɂ‚¢‚Ä‚Í3ŒQŠÔ‚Å·‚ª”F‚ß‚ç‚ê‚È‚©‚Á‚½¡‚±‚ÌŒ‹‰Ê‚©‚ç,‘¤“ª—t‚Ä‚ñ‚©‚ñ‚É‚¨‚¯‚éŠC”nˆÞk‚Í,¶‰ºŽž‚â‘Sg‚¯‚¢‚ê‚ñ”­ìŽž‚Ì’áŽ_‘fó‘Ô‚É‚æ‚é‚à‚̂ł͂Ȃ­,”]‹ÇŠ‚Ì”½•œ‚·‚é‚Ä‚ñ‚©‚ñ«”­ŽË‚ÆŠÖ˜A‚·‚é‰Â”\«‚ªŽ¦´‚³‚ê,ŠC”nˆÞk‚Ì‹@˜‚ðl‚¦‚邤‚¦‚Å‹»–¡[‚­Žv‚í‚ꂽB en-copyright= kn-copyright= en-aut-name=SatoKeiko en-aut-sei=Sato en-aut-mei=Keiko kn-aut-name=²“¡Œ\Žq kn-aut-sei=²“¡ kn-aut-mei=Œ\Žq aut-affil-num=1 ORCID= en-aut-name=OkamotoMotoi en-aut-sei=Okamoto en-aut-mei=Motoi kn-aut-name=‰ª–{Šî kn-aut-sei=‰ª–{ kn-aut-mei=Šî aut-affil-num=2 ORCID= en-aut-name=JojaIkuo en-aut-sei=Joja en-aut-mei=Ikuo kn-aut-name=ã’…ˆè•v kn-aut-sei=ã’… kn-aut-mei=ˆè•v aut-affil-num=3 ORCID= en-aut-name=NakatsuTakeshi en-aut-sei=Nakatsu en-aut-mei=Takeshi kn-aut-name=’†’ÕŽu kn-aut-sei=’†’à kn-aut-mei=•Žu aut-affil-num=4 ORCID= en-aut-name=MorimotoKiyoshi en-aut-sei=Morimoto en-aut-mei=Kiyoshi kn-aut-name=X–{´ kn-aut-sei=X–{ kn-aut-mei=´ aut-affil-num=5 ORCID= en-aut-name=HayabaraToshiyuki en-aut-sei=Hayabara en-aut-mei=Toshiyuki kn-aut-name=‘Œ´•q”V kn-aut-sei=‘Œ´ kn-aut-mei=•q”V aut-affil-num=6 ORCID= en-aut-name=KurodaShigetoshi en-aut-sei=Kuroda en-aut-mei=Shigetoshi kn-aut-name=•“cd—˜ kn-aut-sei=•“c kn-aut-mei=d—˜ aut-affil-num=7 ORCID= affil-num=1 en-affil= kn-affil=‘—§—×{Š“ì‰ªŽR•a‰@_Œo“à‰È¥—Õ°Œ¤‹†•” affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠwˆã—ËZp’ZŠú‘åŠw•”‰q¶‹ZpŠw‰È affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•úŽËüˆãŠw‹³Žº affil-num=4 en-affil= kn-affil=‰ªŽRŽs—§Žs–¯•a‰@_Œo“à‰È affil-num=5 en-affil= kn-affil=ìˆã‰È‘åŠw_Œo¸_ˆãŠw‹³Žº affil-num=6 en-affil= kn-affil=‘—§—×{Š“ì‰ªŽR•a‰@_Œo“à‰È¥—Õ°Œ¤‹†•” affil-num=7 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”_Œo¸_ˆãŠw‹³Žº en-keyword=‘¤“ª—t‚Ä‚ñ‚©‚ñ (temporal lobe epilepsy) kn-keyword=‘¤“ª—t‚Ä‚ñ‚©‚ñ (temporal lobe epilepsy) en-keyword=ŠC”nˆÏk (hippocampal atrophy) kn-keyword=ŠC”nˆÏk (hippocampal atrophy) en-keyword=œë•aŠúŠÔ (clinical history) kn-keyword=œë•aŠúŠÔ (clinical history) en-keyword=MRI kn-keyword=MRI en-keyword=”­ìŠÔŸ[Šú”]”g (interictal EEG foci) kn-keyword=”­ìŠÔŸ[Šú”]”g (interictal EEG foci) END start-ver=1.4 cd-journal=joma no-vol=103 cd-vols= no-issue=7-8 article-no= start-page=951 end-page=962 dt-received= dt-revised= dt-accepted= dt-pub-year=1991 dt-pub=199108 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=The cyclic AMP-generating system of cobalt-induced epileptic cerebral cortex kn-title=ƒRƒoƒ‹ƒg—U“±‚Ä‚ñ‚©‚ñ«‘å”]”玿‚̃TƒCƒNƒŠƒbƒN AMP ‡¬Œn‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=A cobalt chloride solution was injected into the unilateral sensorimotor cortex of rats to induce epileptic activity. The cyclic AMP contents of slices incubated with or without adenosine and 2-chloroadenosine were determined in four cortical areas after electroencephalography and behavioral examination in cobalt-injected rats. Electrographic spike activity appeared immediately after injection of cobalt. In the majority of cobalt-injected rats, the spike activity was dominant in the primary epileptic region of the cortex. The spike frequency reached a maximum level two to three weeks after the injection and declined thereafter. The electrographic activity was followed by abnormal behavior. Adenosine and 2-chloroadenosine elevated the cyclic AMP levels in the cortical slices 6-to 10-fold and 10-to 16-fold, respectively. The elicitation of cyclic AMP accumulation was strongly inhibited by the adenosine antagonist 8-phenyltheophylline. The cyclic AMP accumulation elicited by adenosine or 2-chloroadenosine was increased in the primary cortical area of cobalt-induced epilepsy, but in the other cortical areas there was no deviation in cyclic AMP accumulation. The increase in cyclic AMP accumulation was observed regardless of the presence or absence of the adenosine uptake inhibitor dipyridamole, phosphodiesterase inhibitor Ro 20-1724, and adenosine deaminase. The increased accumulation of cyclic AMP in the primary epileptic cortex was detected as early as 8 days after the injection. The cyclic AMP accumulation slightly increased thereafter. It reached a plateau 17 to 19 days after the injection and then turned to the control levels, in harmony with the electrographic and behavioral profiles. These findings suggest that alterations in adenosine-sensitive generation of cyclic AMP in the primary epileptic region of the cortex are part of the neurochemical process of cobalt-induced epilepsy. en-copyright= kn-copyright= en-aut-name=AsakiHideki en-aut-sei=Asaki en-aut-mei=Hideki kn-aut-name=ó–ØGŽ÷ kn-aut-sei=ó–Ø kn-aut-mei=GŽ÷ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”‘æˆê¶—Šw‹³Žº en-keyword=ƒTƒCƒNƒŠƒbƒN AMP kn-keyword=ƒTƒCƒNƒŠƒbƒN AMP en-keyword=ƒAƒfƒmƒVƒ“ kn-keyword=ƒAƒfƒmƒVƒ“ en-keyword=2 - ƒNƒƒƒAƒfƒmƒVƒ“ kn-keyword=2 - ƒNƒƒƒAƒfƒmƒVƒ“ en-keyword=ƒRƒoƒ‹ƒg—U“±‚Ä‚ñ‚©‚ñ kn-keyword=ƒRƒoƒ‹ƒg—U“±‚Ä‚ñ‚©‚ñ en-keyword=ƒ‰ƒbƒg‘å”]”玿 kn-keyword=ƒ‰ƒbƒg‘å”]”玿 END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2008 dt-pub=20080930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=¬Ž™‚Ä‚ñ‚©‚ñгŽÒ‚É‚¨‚¯‚é•¡ŽG•”•ª”­ìdÏó‘Ô kn-title=Complex partial status epilepticus in children with epilepsy en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=KikumotoKenichi en-aut-sei=Kikumoto en-aut-mei=Kenichi kn-aut-name=‹e–{Œ’ˆê kn-aut-sei=‹e–{ kn-aut-mei=Œ’ˆê aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol=104 cd-vols= no-issue=11-12 article-no= start-page=1023 end-page=1032 dt-received= dt-revised= dt-accepted= dt-pub-year=1992 dt-pub=199212 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Effects of ferric citrate or hyperoxygenation on guanidino compounds in mouse organs kn-title=ƒNƒGƒ“Ž_“S“Š—^‹y‚уŽ_‘f•‰‰×ƒ}ƒEƒX‚̃OƒAƒjƒWƒm‰»‡•¨‚̕ϓ®‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=The guanidino compounds in various mouse organs after i.p. administration of ferric citrate(Fe) and after inhalation of pure oxygen(O(2)) were studied. Guanidinoacetic acid and N-acetylarginine levels were markedly higher in the kidney, and they decreased after administration of Fe or inhalation of O(2). Creatinine decreased in the liver after administration of Fe, and it decreased in the liver and muscle after inhalation of O(2). ƒÁ-Guanidinobutyric acid level was significantly higher in the normal liver, but decreased after administration of Fe or inhalation of O(2). Arginine(Arg) increased in the kidney and muscle after administration of Fe, while it decreased in the liver. Arg decreased in the kidney and the muscle after inhalation of O(2). Methylguanidine(MG) increased in the brain after administration of Fe or inhalation of O(2). However, MG decreased in the liver after administration of Fe, and also decreased in the liver, kidney and muscle after inhalation of O(2). MG increased only in the brain. This finding suggested that the reactive oxygen species(O(2)(-), H(2)O(2), EOH) were most effective there, because oxygen consumpution in the brain was much more than in the other organs. en-copyright= kn-copyright= en-aut-name=WatanabeSeigo en-aut-sei=Watanabe en-aut-mei=Seigo kn-aut-name=“nç²ÈŒá kn-aut-sei=“nç² kn-aut-mei=ÈŒá aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•‘®•ªŽq×–EˆãŠwŒ¤‹†Ž{Ý_Œoî•ñŠw•”–å en-keyword=hyperoxygenation kn-keyword=hyperoxygenation en-keyword=iron ion kn-keyword=iron ion en-keyword=guanidino compounds kn-keyword=guanidino compounds en-keyword=methylganidine kn-keyword=methylganidine en-keyword=free radicals kn-keyword=free radicals END start-ver=1.4 cd-journal=joma no-vol=105 cd-vols= no-issue=11-12 article-no= start-page=977 end-page=986 dt-received= dt-revised= dt-accepted= dt-pub-year=1993 dt-pub=19931231 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Developmental changes in the serotonergic system in El mouse brain kn-title=¬’·‚¨‚æ‚Ñ‚¯‚¢‚ê‚ñ€”õ«Šl“¾‚É”º‚¤ El ƒ}ƒEƒX”]“àƒZƒƒgƒjƒ“‘ãŽÓ‚̕ϓ®‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=El mice manifest epileptiform seizures which are gradually elicited by tossing stimulation once a week from 5 to 10 weeks of ages. It was reported that brain monoamines, especially serotonin (5-HT), are important factors in seizure susceptivity. In this study, we observed changes in brain 5-HT and its metabolite, 5-hydroxyindolacetic acid (5-HIAA), and its metabolic enzymes, tryptophan hydroxylase (Trp-OHase) and monoamine oxidase-A (MAO-A) , during growth with and without tossing stimulation. In non-stimulated El mice, the 5-HT level was lower at 6 and 7 weeks than that in other ages, and the 5-HIAA level was generally lower in older mice. In stimulated El mice, the 5-HT level was higher after the first stimulation, lower at 8 weeks, and then higher again at 10 weeks. However, 5-HIAA levels were generally higher in older mice. The Trp-OHase activity was higher at 8 and 10 weeks, and the MAO-A activity was higher at 8 weeks compared to that of non-stimulated El mice. These findings suggest that a disordered release and metabolism of 5-HT influences the development of the epileptiform seizures induced by tossing stimulation. en-copyright= kn-copyright= en-aut-name=SuyamaKeiko en-aut-sei=Suyama en-aut-mei=Keiko kn-aut-name=“©ŽRƒPƒCŽq kn-aut-sei=“©ŽR kn-aut-mei=ƒPƒCŽq aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•ªŽq×–EˆãŠwŒ¤‹†Ž{Ý_Œoî•ñŠw•”–å en-keyword=El mouse seizures kn-keyword=El mouse seizures en-keyword=serotonin kn-keyword=serotonin en-keyword=5-hydroxyindolacetic acid kn-keyword=5-hydroxyindolacetic acid en-keyword=tryptophan hydroxylase kn-keyword=tryptophan hydroxylase en-keyword=monoamine oxidase-A kn-keyword=monoamine oxidase-A END start-ver=1.4 cd-journal=joma no-vol=106 cd-vols= no-issue=1-2 article-no= start-page=103 end-page=115 dt-received= dt-revised= dt-accepted= dt-pub-year=1994 dt-pub=199402 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Immunohistocemical analysis of glutamic acid, ƒÁ-aminobutyric acid, and glial fibrillary acidic protein positive cells in the hippocampus of E1 mice kn-title=E1ƒ}ƒEƒX‚ÌŠC”n‚É‚¨‚¯‚éƒOƒ‹ƒ^ƒ~ƒ“Ž_,ƒÁ-ƒAƒ~ƒm—Ž_‹y‚Ñ glial fibrillary acidic protein ‚̖Ɖu‘gD‰»Šw“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=Glutamic acid, ƒÁ-aminobutyric acid and glial fibrillary accidic protenin positive cells in the hippocampus of E1 mice and ddY mice were examined immunohistochemically. The shape of glutamic acid positive cells in CA1, CA2, CA3 and CA4 of hippocampus were expanded compar-ed to that of ddY mice. There was a space between cells and cells containing glutamic acid and the nucleus of such cells was larger in the CA1 of E1 mice than that of ddY mice. The glutamic acid cells were irregular and the nucleus was larger in the gyrus dentantus of E1 mice than that of ddY mice. There was an intermittence in the process of glutamic acid cells in the area of of str. radiatum of E1 mice. ƒÁ-Aminobutyric acid-posititve cells seemed to be expanded in CA1 of CA2, CA3, and CA4 and gyrus dentatus and there was space between such cells in the CA1 of E1 mice. Large ƒÁ-aminobutyric acid positive cells, which were located close to the gyrus dentatus in ddY mice, were not found in E1 mice. The number of ƒÁ-aminobutyric acid-positive cells was lower in E1 mice than in ddY mice. A greater number of glial fibrillary acidic protein postive cells was found in the area of the hippocampus in E1 mice than in ddY mice. These results suggest that E1 mice are genetically epileptic mice. en-copyright= kn-copyright= en-aut-name=SuhMoon-Suk en-aut-sei=Suh en-aut-mei=Moon-Suk kn-aut-name=™•¶Žà kn-aut-sei=™ kn-aut-mei=•¶Žà aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•ªŽq×–EˆãŠwŒ¤‹†Ž{Ý_Œoî•ñŠw•”–å en-keyword=E1ƒ}ƒEƒX kn-keyword=E1ƒ}ƒEƒX en-keyword=ƒOƒ‹ƒ^ƒ~ƒ“Ž_ kn-keyword=ƒOƒ‹ƒ^ƒ~ƒ“Ž_ en-keyword=ƒÁ-ƒAƒ~ƒm—Ž_ kn-keyword=ƒÁ-ƒAƒ~ƒm—Ž_ en-keyword=–Ɖu‘gD‰»Šw kn-keyword=–Ɖu‘gD‰»Šw en-keyword=ŠC”n kn-keyword=ŠC”n END start-ver=1.4 cd-journal=joma no-vol=109 cd-vols= no-issue=1-2 article-no= start-page=1 end-page=6 dt-received= dt-revised= dt-accepted= dt-pub-year=1997 dt-pub=19970228 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Cerebral dysgenesis and psychomotor retardation in neonatal epilepsy kn-title=V¶Ž™Šú”­Ç‚̂Ăñ‚©‚ñ‚É‚¨‚¯‚é”]Œ`¬áŠQ‚¨‚æ‚ÑSgáŠQ‚ɂ‚¢‚Ă̌Ÿ“¢ en-subtitle= kn-subtitle= en-abstract= kn-abstract=A clinical and neuroradiological study was carried out to clarify the relationship among cerebral dysgenesis, psychomotor retardation and neonatal epilepsy. Twenty-one cases with epilepsy developed within four weeks after birth were selected among 770 in-patients with childhood epilepsy. They consisted of one benign familial neonatal convulsion, nine of early myoclonic encephalopathy, four of Ohtahara syndrome, six of symptomatic localizationrelated epilepsy, and one of undetermined epilepsy. Seven cases with non specific types of epilepsies were investigated in detail. They developed into four of frontal lobe epilepsy, one of temporal lobe epilepsy and one severe epilepsy with multiple independent spike foci. Psychomotor retardation was observed in six of seven cases, and cerebral dysgenesis was considered to be important as an etiological factor. Proton MR spectroscopy revealed the decrease in the ratio of N-acetylaspartate/choline in the area with heterotopic gray matter and in the side of hemimegalencephaly, contrasted with a contralateral area without lesions. These findings can be inferred to reflect the decreased numbers of neuronal cell population or reduced metabolism in the lesions. en-copyright= kn-copyright= en-aut-name=SanadaSatoshi en-aut-sei=Sanada en-aut-mei=Satoshi kn-aut-name=^“c•q kn-aut-sei=^“c kn-aut-mei=•q aut-affil-num=1 ORCID= en-aut-name=OkaEiji en-aut-sei=Oka en-aut-mei=Eiji kn-aut-name=‰ªú^ŽŸ kn-aut-sei=‰ª kn-aut-mei=ú^ŽŸ aut-affil-num=2 ORCID= en-aut-name=OhtaharaShunsuke en-aut-sei=Ohtahara en-aut-mei=Shunsuke kn-aut-name=‘å“cŒ´r•ã kn-aut-sei=‘å“cŒ´ kn-aut-mei=r•ã aut-affil-num=3 ORCID= en-aut-name=KawaharaMichiko en-aut-sei=Kawahara en-aut-mei=Michiko kn-aut-name=‰ÍŒ´“¹Žq kn-aut-sei=‰ÍŒ´ kn-aut-mei=“¹Žq aut-affil-num=4 ORCID= en-aut-name=SakaeKatsuyoshi en-aut-sei=Sakae en-aut-mei=Katsuyoshi kn-aut-name=‰hŸ”ü kn-aut-sei=‰h kn-aut-mei=Ÿ”ü aut-affil-num=5 ORCID= en-aut-name=HirakiYoshio en-aut-sei=Hiraki en-aut-mei=Yoshio kn-aut-name=•½–ØË•v kn-aut-sei=•½–Ø kn-aut-mei=Ë•v aut-affil-num=6 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”¬Ž™_Œo‰È affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”¬Ž™_Œo‰È affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”¬Ž™_Œo‰È affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•úŽËü‰È affil-num=5 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•úŽËü‰È affil-num=6 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•úŽËü‰È en-keyword=V¶Ž™Šú kn-keyword=V¶Ž™Šú en-keyword=‹ÇÝŠÖ˜A«‚Ä‚ñ‚©‚ñ kn-keyword=‹ÇÝŠÖ˜A«‚Ä‚ñ‚©‚ñ en-keyword=SgáŠQ kn-keyword=SgáŠQ en-keyword=”]Œ`¬áŠQ kn-keyword=”]Œ`¬áŠQ en-keyword=MR ƒXƒyƒNƒgƒƒXƒRƒs[ kn-keyword=MR ƒXƒyƒNƒgƒƒXƒRƒs[ END start-ver=1.4 cd-journal=joma no-vol=106 cd-vols= no-issue=7-8 article-no= start-page=799 end-page=809 dt-received= dt-revised= dt-accepted= dt-pub-year=1994 dt-pub=199408 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=An electroclinical study on latent epilepsy in childhood kn-title=¬Ž™Šú‚ÌöÝ«‚Ä‚ñ‚©‚ñ‚Ì”]”g‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=Clinical and electroencephalographic studies were carried out to clarify the characteristics of latent epilepsy (LE) in children and to obtain criteria for treatment. LE was defined as a condition manifesting epileptic EEG abnormalities without any clinical epilepsy, febrile convulsion or other seizures. Three hundred and thirty-nine children with LE seen at the Department of Child Neurology, Okayama University Hospital were divided into four groups by their etiological backgrounds (e. g., organic brain damage and convulsive predisposition) and were compared with 149 controls with clinical epilepsy. Clinical epileptic seizures appeared in 14 (4.1%) of the 339 children during follow-up of two months to 19 years. Thirteen of the 14 cases belonged to the organic brain damage group. The EEG findings in children susceptible to clinical seizures consisted of slow spike-wave, generalized cortico-subcortical discharges, multiple focal cortical discharges, focal discharges with forcal slow wave, and discharges activated by hyperventilation. The EEG findings in children not disposed to develop clinical epilepsy consisted of sharp wave, small sharp wave, Rolandic spike, parietal focal spike, and photo-sensitivity discharges in adolescence. Convulsive and epileptic predisposition was not regarded as a risk factor in clinical epilepsy. On the basis of these findings, criteria for antiepileptic drug therapy for LE were proposed. en-copyright= kn-copyright= en-aut-name=OhnoShigeru en-aut-sei=Ohno en-aut-mei=Shigeru kn-aut-name=‘å–ì”É kn-aut-sei=‘å–ì kn-aut-mei=”É aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”¬Ž™_ŒoŠw‹³Žº en-keyword=öÝ«‚Ä‚ñ‚©‚ñ kn-keyword=öÝ«‚Ä‚ñ‚©‚ñ en-keyword=‚Ä‚ñ‚©‚ñ kn-keyword=‚Ä‚ñ‚©‚ñ en-keyword=‚Ä‚ñ‚©‚ñ”g kn-keyword=‚Ä‚ñ‚©‚ñ”g en-keyword=R‚Ä‚ñ‚©‚ñÜ kn-keyword=R‚Ä‚ñ‚©‚ñÜ en-keyword=”]”g kn-keyword=”]”g END start-ver=1.4 cd-journal=joma no-vol=106 cd-vols= no-issue=7-8 article-no= start-page=757 end-page=762 dt-received= dt-revised= dt-accepted= dt-pub-year=1994 dt-pub=199408 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Influence of the combined treatment with phenytoin or valproate on serum concentration of carbamazepine kn-title=ŒŒ´’†ƒJƒ‹ƒoƒ}ƒ[ƒsƒ“”Z“x‚É‹y‚Ú‚·ƒtƒFƒjƒgƒCƒ“‚¨‚æ‚уoƒ‹ƒvƒŽ_•¹—p‚̉e‹¿ en-subtitle= kn-subtitle= en-abstract= kn-abstract=To clarify the pharmacokinetic interaction in poly-therapy for epilepsy, the serum concentration of carbamazepine (CZB) was measured in epileptic patients to whom CBZ had been prescribed chronically with or without phenytoin (PHT) and sodium valproate (VPA). The serum CBZ concentrations increased with increasing doses of CBZ, but increased less at higher doses. Chiliren (<12 yrs) showed lower serum CBZ concentrations than patients 12 years old and older. The L/D ratios (L : CBZ level, D : dose/body weight) were significantly decreased by the combined treatment with PHT and VPA in a dose-dependent manner, probably due to an induction of metabolizing enzyme. These findings suggest that especially in the case of change of the drug therapy from mono-therapy to mono therapy, careful monitoring of serum concentration is necessary. en-copyright= kn-copyright= en-aut-name=KishimaMiyuki en-aut-sei=Kishima en-aut-mei=Miyuki kn-aut-name=‹S“ˆ‚݂䂫 kn-aut-sei=‹S“ˆ kn-aut-mei=‚݂䂫 aut-affil-num=1 ORCID= en-aut-name=YaoKazuhisa en-aut-sei=Yao en-aut-mei=Kazuhisa kn-aut-name=–î”ö˜a‹v kn-aut-sei=–î”ö kn-aut-mei=˜a‹v aut-affil-num=2 ORCID= en-aut-name=YasuharaKanako en-aut-sei=Yasuhara en-aut-mei=Kanako kn-aut-name=ˆÀŒ´‰Á“ÞŽq kn-aut-sei=ˆÀŒ´ kn-aut-mei=‰Á“ÞŽq aut-affil-num=3 ORCID= en-aut-name=SuemaruKatsuya en-aut-sei=Suemaru en-aut-mei=Katsuya kn-aut-name=––ŠÛŽ–î kn-aut-sei=––ŠÛ kn-aut-mei=Ž–î aut-affil-num=4 ORCID= en-aut-name=FurunoKatsushi en-aut-sei=Furuno en-aut-mei=Katsushi kn-aut-name=ŒÃ–쟎u kn-aut-sei=ŒÃ–ì kn-aut-mei=ŸŽu aut-affil-num=5 ORCID= en-aut-name=OishiRyozo en-aut-sei=Oishi en-aut-mei=Ryozo kn-aut-name=‘åΗ¹ŽO kn-aut-sei=‘åÎ kn-aut-mei=—¹ŽO aut-affil-num=6 ORCID= en-aut-name=GomitaYutaka en-aut-sei=Gomita en-aut-mei=Yutaka kn-aut-name=ŒÜ–¡“c—T kn-aut-sei=ŒÜ–¡“c kn-aut-mei=—T aut-affil-num=7 ORCID= en-aut-name=OhtaharaShunsuke en-aut-sei=Ohtahara en-aut-mei=Shunsuke kn-aut-name=‘å“cŒ´r•ã kn-aut-sei=‘å“cŒ´ kn-aut-mei=r•ã aut-affil-num=8 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•‘®•a‰@–òÜ•” affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•‘®•a‰@–òÜ•” affil-num=3 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•‘®•a‰@–òÜ•” affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•‘®•a‰@–òÜ•” affil-num=5 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•‘®•a‰@–òÜ•” affil-num=6 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•‘®•a‰@–òÜ•” affil-num=7 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•‘®•a‰@–òÜ•” affil-num=8 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”¬Ž™_ŒoŠw‹³Žº en-keyword=ƒJƒ‹ƒoƒ}ƒ[ƒsƒ“ kn-keyword=ƒJƒ‹ƒoƒ}ƒ[ƒsƒ“ en-keyword=ƒtƒFƒjƒgƒCƒ“ kn-keyword=ƒtƒFƒjƒgƒCƒ“ en-keyword=ƒoƒ‹ƒvƒŽ_ kn-keyword=ƒoƒ‹ƒvƒŽ_ en-keyword=ŒŒ´’†”Z“x kn-keyword=ŒŒ´’†”Z“x en-keyword=–ò•¨‘ŠŒÝì—p kn-keyword=–ò•¨‘ŠŒÝì—p END start-ver=1.4 cd-journal=joma no-vol=107 cd-vols= no-issue=7-8 article-no= start-page=131 end-page=141 dt-received= dt-revised= dt-accepted= dt-pub-year=1995 dt-pub=19950831 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Adenosines as preventive preparations of post-traumatic epilepsy kn-title=ƒAƒfƒmƒVƒ“ŠÖ˜A•¨Ž¿‚É‚æ‚éŠO«‚Ä‚ñ‚©‚ñ”­Ç—\–h‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=As oxidation of neural membranes by reactive oxygen species (ROS), especially hydroxyl radicals (EOH), is involved in the biochemical pathogenesis of post-traumatic epilepsy, post-traumatic epilepsy is thought to be prevented by treatment with ROS scavengers. In the present study, I first examined the effects of adenosine (Ado), 2-chloroadenosine (CI-Ado) and guanosine on EOH and superoxide anion (O(-)(2)), generated by the Fenton reagent and the hypoxanthine-xanthine oxidase system, respectively, using electron spin resonance spectrometry. I also examined the effecta of Ado and Cl-Ado on the occurrence of epileptic discharges on the electrocorticogram (ECoG) induced by FeCl(3) injection (500nmol) into the sensorimotor cortex of rats, i.e., a model of an experimental post-traumatic epilepsy. Although O(-)(2) was not scavenged, EOH were scavenged by Ado and Cl-Ado dose-dependently. The scavenging activity of Ado was 4 times stronger then thst of Cl-Ado. On the ECoG of rats given FeCl(3), sporadic spike discharges, polyspikes and/or ictal patterns started to be observed 15-90 min after the injection. Epileptic discharges did not appear or their occurrence was delayed by the intraperitioneal injection of Ado (5mg/kg) or Cl-Ado (1mg/kg) 30 min prior to the FeCl(3) injection, although Cl-Ado showed a chronotropic action. Thus Ado and Ci-Ado may be useful in the prevention and the attenuation of progression of post-traumatic epilepsy by scavenging EOH and by their anticonvulsant effect. en-copyright= kn-copyright= en-aut-name=TomaJunji en-aut-sei=Toma en-aut-mei=Junji kn-aut-name=“–^ƒ“ñ kn-aut-sei=“–^ kn-aut-mei=ƒ“ñ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•‘®•ªŽq×–EˆãŠwŒ¤‹†Ž{Ý_Œoî•ñŠw•”–å en-keyword=adenosine kn-keyword=adenosine en-keyword=chloroadenosine kn-keyword=chloroadenosine en-keyword=radical scavenger kn-keyword=radical scavenger en-keyword=post-traumatic epilepsy kn-keyword=post-traumatic epilepsy en-keyword=experimental epilepsy kn-keyword=experimental epilepsy END start-ver=1.4 cd-journal=joma no-vol=107 cd-vols= no-issue=7-8 article-no= start-page=99 end-page=109 dt-received= dt-revised= dt-accepted= dt-pub-year=1995 dt-pub=19950831 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=An electroclinical study of localization-related epilepsies occurring before 6 months of age kn-title=¶Œã6ƒ•ŒŽ–¢–ž”­Ç‚Ì‹ÇÝŠÖ˜A«‚Ä‚ñ‚©‚ñ‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=To clarify the characteristics of localization-related epilepsies occurring before 6 monthes of age, I carried out an electroclinical study on 28 cases which had been followed up for more than one year after the onset. The subjects were divided into two groups : the controlled group (8 cases) and the refractory group (20 cases). The controlled group was defined as the subjects whose seizures were suppressed within one year after the onset and the other subjects were classified into the refractory group. The characteristies of the refractory group were as follows : Most cases had serious underlying pathologies. The seizure type of most cases was simple partial seizure or complex partial seizure or complex partial seizure without secondary generalization. The inter-ictal EEG showed focal abnormalities and severe dysrrythmia on the basic pattern associated with mulitifocal spikes in most cases. Some cases developed West syndrome after localization-related epilepsies, and generalized seizures or pseudoabsences appeared later in some other cases. In conclusion, a comprehensive assessment and an intensive follow-up of clinical and EEG manifestations are of great value for determining the prognosis localization-related epilepsies occurring in early infancy. en-copyright= kn-copyright= en-aut-name=OhmoriIori en-aut-sei=Ohmori en-aut-mei=Iori kn-aut-name=‘åŽçˆÉD kn-aut-sei=‘åŽç kn-aut-mei=ˆÉD aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”¬Ž™_ŒoŠw‹³Žº en-keyword=‹ÇÝŠÖ˜A«‚Ä‚ñ‚©‚ñ kn-keyword=‹ÇÝŠÖ˜A«‚Ä‚ñ‚©‚ñ en-keyword=“‚Ä‚ñ‚©‚ñ kn-keyword=“‚Ä‚ñ‚©‚ñ en-keyword=—\Œã kn-keyword=—\Œã en-keyword=”]”g kn-keyword=”]”g en-keyword=“ûŽ™Šú kn-keyword=“ûŽ™Šú END start-ver=1.4 cd-journal=joma no-vol=110 cd-vols= no-issue=1-6 article-no= start-page=39 end-page=51 dt-received= dt-revised= dt-accepted= dt-pub-year=1998 dt-pub=19980625 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Analysis of ictal EEGs in West syndrome kn-title=West ÇŒóŒQ‚Ì”­ìŽž”]”g‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=Although tonic spasms (TS) observed in West syndrome(WS) are regarded as generalized seizures, the mechanism of their occurrence has not yet been fully elucidated. We analyzed ictal EEGs of TS to determine the mechanism and to clarify the role of cortical pathology in the occurrence of TS. Of 53 infants with WS, we classified cryptogenic cases as Group ‡T. Symptomatic cases were classified into 2 groups : Group ‡U consisted of those without partial seizures during the period of WS and Group 3 consisted of those with partial seizures. We analyzed 7283 ictal EEGs of TS regarding the following 5 points : 1) patterns of ictal EEGs, 2) frequency of isolated TS, 3) asymmetry of ictal EEGs, 4) spasm-spasm intervals, and 5) duration of ictal EEGs of each TS. We concluded that the asymmetry of ictal EEGs and the "rhythmic slow activity" immediately following ictal EEGs of TS were related to cortical pathology. Since "rhythmic slow activities" were often observed in Group ‡V and appeared at the same regions as those in ictal EEGs of concomittant partial seizures, they were considered to be peculiar EEG patterns related to cortical pathologic lesions. en-copyright= kn-copyright= en-aut-name=AsanoTakashi en-aut-sei=Asano en-aut-mei=Takashi kn-aut-name=ó–ìF kn-aut-sei=ó–ì kn-aut-mei=F aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”¬Ž™_ŒoŠwuÀ en-keyword=West ÇŒóŒQ kn-keyword=West ÇŒóŒQ en-keyword=”­ìŽž”]”g kn-keyword=”­ìŽž”]”g en-keyword=Tonic spasms kn-keyword=Tonic spasms en-keyword=•”•ª”­ì kn-keyword=•”•ª”­ì END start-ver=1.4 cd-journal=joma no-vol=107 cd-vols= no-issue=7-8 article-no= start-page=69 end-page=78 dt-received= dt-revised= dt-accepted= dt-pub-year=1995 dt-pub=19950831 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Effect of zonisamide on neurotransmitter release from hippocampal slice of E1 mice : A study of neurotransmitter release using an improved experimemtal system kn-title=‰ü—ÇŒ^_Œo“`’B•¨Ž¿•úo‘ª’è‘•’u‚É‚æ‚éE1ƒ}ƒEƒXŠC”nؕЂæ‚è‚Ì_Œo“`’B•¨Ž¿•úo‚ÆR‚Ä‚ñ‚©‚ñ–òƒ]ƒjƒTƒ~ƒh‚̉e‹¿‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract=Using an experimental apparatus for estimating neurotransmitter release from brain slices, which involved an improved type of perfusion chamber and more well-controlled tube lines than the previous one were aspartic acid and ƒÁ-aminobutyric acid (GABA) release from hippocampal slices from epileptic E1 mice estimated more exactly and stably. Zonisamide had no effect on the aspartic acid release from hippocampal slices of E1 mice by zonisamide. However, zonisamide accelerated dose dependently GABA release from hippocampal slices of non-stimulated E1 mice, though no such acceleration was observed in stimulated E1 mice, i. e., repeatedly convulsed E1 mice. en-copyright= kn-copyright= en-aut-name=EndoAtsushi en-aut-sei=Endo en-aut-mei=Atsushi kn-aut-name=‰““¡“Ö kn-aut-sei=‰““¡ kn-aut-mei=“Ö aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•‘®•ªŽq×–EˆãŠwŒ¤‹†Ž{Ý_Œoî•ñŠw•”–å en-keyword=E1ƒ}ƒEƒX kn-keyword=E1ƒ}ƒEƒX en-keyword=ƒAƒXƒpƒ‰ƒMƒ“Ž_ kn-keyword=ƒAƒXƒpƒ‰ƒMƒ“Ž_ en-keyword=ƒÁ-ƒAƒ~ƒm—Ž_ kn-keyword=ƒÁ-ƒAƒ~ƒm—Ž_ en-keyword=ƒ]ƒjƒTƒ~ƒh kn-keyword=ƒ]ƒjƒTƒ~ƒh en-keyword=‚¯‚¢‚ê‚ñ kn-keyword=‚¯‚¢‚ê‚ñ END start-ver=1.4 cd-journal=joma no-vol=116 cd-vols= no-issue=3 article-no= start-page=251 end-page=255 dt-received= dt-revised= dt-accepted= dt-pub-year=2005 dt-pub=20050131 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=West ÇŒóŒQ‚Ì–ò•¨—Ö@ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‘å’ËèñŽq kn-aut-sei=‘å’Ë kn-aut-mei=èñŽq aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘åŠw‰@ˆãŽ•Šw‘‡Œ¤‹†Š@”­’B_Œo•a‘ÔŠw en-keyword=WestÇŒóŒQ kn-keyword=WestÇŒóŒQ en-keyword=“_“ª‚Ä‚ñ‚©‚ñ kn-keyword=“_“ª‚Ä‚ñ‚©‚ñ en-keyword=–ò•¨—Ö@ kn-keyword=–ò•¨—Ö@ en-keyword=—\Œã kn-keyword=—\Œã END start-ver=1.4 cd-journal=joma no-vol=119 cd-vols= no-issue=1 article-no= start-page=41 end-page=47 dt-received= dt-revised= dt-accepted= dt-pub-year=2007 dt-pub=20070501 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=An animal model of status epilepticus induced by massed electrical stimulations to the deep prepiriform cortex kn-title=[•”‘O—œó—t”玿‚ÌŠÔŒ‡“I“d‹CŽhŒƒ‚É‚æ‚é‚Ä‚ñ‚©‚ñ”­ìdσ‚ƒfƒ‹ en-subtitle= kn-subtitle= en-abstract= kn-abstract=Hippocampal damage induced by status epilepticus (SE) has been suggested as the developmental pathway of temporal lobe epilepsy. We developed an experimental model of SE induced by massed electrical stimulations into the deep prepiriform cortex. Stimulations under aminophylline pretreatment more effectively induced SE than those in the absence of aminophylline. Most SE episodes included secondary generalized seizures. Cresyl violet staining indicated neuronal degeneration in CA1 and CA3, 1-2 weeks after the SE. Mild neuronal loss was observed 8 weeks after the SE, although there were no obvious histological changes in the hilus. Immunoreactivity for GluR1, a subunit of the AMPA receptors, was reduced in CA3 and the hilus starting 1 week after SE, indicating a discrepancy between the distributions of neuronal damage and the GluR1 decrement. The present model serves as a useful model of SE. Further improvement of this method will make it an effective tool for understanding the developmental process of temporal lobe epilepsy. en-copyright= kn-copyright= en-aut-name=KoyamaFumihiko en-aut-sei=Koyama en-aut-mei=Fumihiko kn-aut-name=¬ŽR•¶•F kn-aut-sei=¬ŽR kn-aut-mei=•¶•F aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw‘剪ŽR‘åŠw‘åŠw‰@ˆãŽ•–òŠw‘‡Œ¤‹†‰È ¸__Œo•a‘ÔŠw en-keyword=‚¯‚¢‚ê‚ñ”­ìdÏ(status epilepticus) kn-keyword=‚¯‚¢‚ê‚ñ”­ìdÏ(status epilepticus) en-keyword=[•”‘O—œó—t”玿(deep prepiriform cortex) kn-keyword=[•”‘O—œó—t”玿(deep prepiriform cortex) en-keyword=”½•œ“d‹CŽhŒƒ(massed electrical stimulations) kn-keyword=”½•œ“d‹CŽhŒƒ(massed electrical stimulations) en-keyword=AMPAŒ^Žó—e‘Ì(AMPA receptors) kn-keyword=AMPAŒ^Žó—e‘Ì(AMPA receptors) en-keyword=ƒ‰ƒbƒg(rat) kn-keyword=ƒ‰ƒbƒg(rat) END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2008 dt-pub=20080325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ƒ}ƒEƒX‚Ì“d‹C¶—Šw“IŽè–@‚ð—p‚¢‚½‚Ä‚ñ‚©‚ñ‚ÌV‚µ‚¢•]‰¿•û–@‚ÆR‚Ä‚ñ‚©‚ñ–ò‚̉e‹¿ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=MurakamiAya en-aut-sei=Murakami en-aut-mei=Aya kn-aut-name=‘ºã— kn-aut-sei=‘ºã kn-aut-mei=— aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2008 dt-pub=20080325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=‚Ä‚ñ‚©‚ñ«ƒXƒpƒYƒ€‚Ì”­ìŽž”]”g‚É‚¨‚¯‚éƒKƒ“ƒ}—¥“®‚̃XƒyƒNƒgƒ‹“Á« kn-title=Spectral characteristics of EEG gamma rhythms associated with epileptic spasms en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=InoueTakushi en-aut-sei=Inoue en-aut-mei=Takushi kn-aut-name=ˆäã‘ñŽu kn-aut-sei=ˆäã kn-aut-mei=‘ñŽu aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol=10 cd-vols= no-issue=2 article-no= start-page=69 end-page=76 dt-received= dt-revised= dt-accepted= dt-pub-year=2000 dt-pub=20000324 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=An experimental study on the relation of T2-signal high intensity in MRI to histopathological changes in the kainic acid model of temporal lobe epilepsy in rats. kn-title=ƒ‰ƒbƒg‚É‚¨‚¯‚éƒJƒCƒjƒ“Ž_‚¯‚¢‚ê‚ñ”­ìdÏŒã‚ÌMRIŠŒ©‚Æ•a—ŠŒ©‚ÌŠÖŒW en-subtitle= kn-subtitle= en-abstract=The relation of T2-signal high intensity areas observed in temporal lobe epilepsy to histopathological changes in limbic structures was examined in the rat kainic acid (KA) model of epilepsy. Male 8-week-old Sprague-Dawley rats were injected with 10mg/kg(i.p.) of KA or saline (control). Repetitive generalized convulsions (stage 3, or stage 4,5 seizures of amygdala kindled seizures) lasted for 3 to 4 hrs. were induced by KA injection in all rats. MRI was recorded on the day before the KA injection and 1, 2, 4, 8 weeks after the injection by fluid-attenuated inversion recovery method under deep pentobarbital anesthesia. Following the last MRI recording, rats were perfused with 4% paraformaldehyde (PFA) from left cardiac ventricle, post-fixed overnight in 4% PFA and brains were embedded in parafin. Coronal brain sections (6ƒÊm) were stained with cresyl violet, or mouse anti-GFAP antibody followed by biotinylated goat anti-mouse IgG and avidin-biotin-peroxidase (vectastain ABC kit). Irregularshaped moderate to severe high T2-signal areas were observed in bilateral piriform and entorhinal cortex in MRI. These high T2-signal areas were ovserved from 1 week after the KA injection to 8 weeks after the injection, and were more prominent in rats elicited stage 4 or 5 seizures than in rats elicited stage 3 seizures. Loss of pyramidal neurons and increased GFAP immunoreactivity were observed in piriform cortex, entorhinal cortex, CA1, subiculum, and hilus of dentate gyrus. The increase of GFAP immunoreactivity, but not the intensity of neuronal loss, in piriform and entorhinal cortex was almost correponded to the size and intensity of T2-signal. However, the increase of GFAP immunoreactivity in hippocampus was not detected as the increase of T2-signal in MRI. These findings indicate that astroglial reactions in piriform and entorhinal cortex are more sensitive to T2-weighted MRI than those in hippocampus. kn-abstract=‘¤“ª—t‚Ä‚ñ‚©‚ñ‚Å‚ÍC‚Ä‚ñ‚©‚ñÅ“_‚Ɉê’v‚µ‚ÄMRI T2‚M†—̈悪Œ©‚ç‚êCFLAIR–@‚Å‚±‚ꂪ‚æ‚è–¾—ĂɂȂ邪C‚±‚ÌMRIŠŒ©‚Æ•a—‘gDŠw“I•ω»‚Ƃ̊֌W‚Í•K‚¸‚µ‚à‚Í‚Á‚«‚肵‚Ä‚¢‚È‚¢B‚»‚±‚ÅCSprague|Dawleyƒ‰ƒbƒg‚ɃJƒCƒjƒ“Ž_iKAj‚Å‚¯‚¢‚ê‚ñ”­ìdÏó‘Ô‚ð‹N‚±‚µCŒoŽž“I‚ÉMRI‚ð‹L˜^‚·‚邯‚Æ‚à‚ÉCƒjƒbƒXƒ‹õFCGFAP–ƉuõF‚ł̕a—‘gDŠw“I•ω»‚𒲂ׂė¼ŽÒ‚ÌŠÖŒW‚ɂ‚¢‚ÄŒŸ“¢‚µ‚½BKAŒQ‚Å‚ÍCMRI‚Å1`8TŠÔŒã‚Ì‚¢‚¸‚ê‚É‚¨‚¢‚Ä‚àpiriform cortex‚©‚çentorhinal cortex‚É‚©‚¯‚Ä•s®Œ`‚ÌT2‚M†—̈悪‚Ý‚ç‚ꂽ‚ªCstage3‚Ì‚¯‚¢‚ê‚ñ”­ì‚µ‚©oŒ»‚µ‚È‚©‚Á‚½ƒ‰ƒbƒg‚Å‚Ístage4C5‚ªoŒ»‚µ‚½ƒ‰ƒbƒg‚É”ä‚ׂĒö“x‚ªŽã‚©‚Á‚½B‘gDŠw“I‚É‚ÍCCA1CsubiculumCpiriform cortexCentorhinal cortex‚Å_Œo×–E‚ÌÁޏC”Zõ×–E‚Ì‘‰Á‚ƈÞkCGFAP–Ɖu”½‰ž‚Ì‘‹­‚ªŒ©‚ç‚ꂽ‚ªCpiriform cortexCentorhinal cortex‚Å‚Ì_Œo×–EÁޏ‚Ì’ö“x‚ÍT2M †‚Ì’ö“x‚Æ‘ŠŠÖ‚¹‚¸CGFAP–Ɖu”½‰ž‚ª‘‹­‚µ‚½—̈æ‚Ɉê’v‚µ‚Ä‚M†‚ª‚Ý‚ç‚ꂽB‚µ‚©‚µCŠC”n‚ÌGFAP–Ɖu”½‰ž‘‹­‚ÍMRIŠŒ©‚É”½‰f‚³‚ꂸC‚±‚ê‚ÍMRI‚̉𑜓x‚ÌŒÀŠE‚É‚à‚æ‚邯l‚¦‚ç‚ꂽB en-copyright= kn-copyright= en-aut-name=SakiyamaJunko en-aut-sei=Sakiyama en-aut-mei=Junko kn-aut-name=ú±ŽR‡Žq kn-aut-sei=ú±ŽR kn-aut-mei=‡Žq aut-affil-num=1 ORCID= en-aut-name=OkamotoMotoi en-aut-sei=Okamoto en-aut-mei=Motoi kn-aut-name=‰ª–{Šî kn-aut-sei=‰ª–{ kn-aut-mei=Šî aut-affil-num=2 ORCID= en-aut-name=KitamuraYoshihiro en-aut-sei=Kitamura en-aut-mei=Yoshihiro kn-aut-name=–k‘º‹gG kn-aut-sei=–k‘º kn-aut-mei=‹gG aut-affil-num=3 ORCID= en-aut-name=YamadaNorihito en-aut-sei=Yamada en-aut-mei=Norihito kn-aut-name=ŽR“c—¹Žm kn-aut-sei=ŽR“c kn-aut-mei=—¹Žm aut-affil-num=4 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•ÛŒ’Šw‰ÈŒŸ¸‹Zp‰ÈŠwêU affil-num=2 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”•ÛŒ’Šw‰ÈŒŸ¸‹Zp‰ÈŠwêU affil-num=3 en-affil= kn-affil=‰ªŽR—ÃŒìƒZƒ“ƒ^[ affil-num=4 en-affil= kn-affil=‰ªŽR‘åŠwˆãŠw•”ˆãŠw‰È_Œo¸_ˆãŠwuÀ en-keyword=ƒJƒCƒjƒ“Ž_ (kainic acid) kn-keyword=ƒJƒCƒjƒ“Ž_ (kainic acid) en-keyword=MRI kn-keyword=MRI en-keyword=FLAIR–@ (FLAIR) kn-keyword=FLAIR–@ (FLAIR) en-keyword=_Œo×–EŽ€ (neuronal death) kn-keyword=_Œo×–EŽ€ (neuronal death) en-keyword=GFAP kn-keyword=GFAP END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2007 dt-pub=20070323 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=[•”‘O—œó—t”玿‚ÌŠÔŒ‡“I“d‹CŽhŒƒ‚É‚æ‚é‚Ä‚ñ‚©‚ñ”­ìdσ‚ƒfƒ‹ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=KoyamaFumihiko en-aut-sei=Koyama en-aut-mei=Fumihiko kn-aut-name=¬ŽR•¶•F kn-aut-sei=¬ŽR kn-aut-mei=•¶•F aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2004 dt-pub=20041231 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=¬Ž™Šú‚Ìöˆö«‹ÇÝŠÖ˜A«‚Ä‚ñ‚©‚ñ‚É‚¨‚¯‚éR‚Ä‚ñ‚©‚ñ–òŒ¸—Ê, ’f–òŒã‚ÌÄ”­‚ÉŠÖ‚·‚錤‹† kn-title=Prognosis after withdrawal of antiepileptic drugs in childhood-onset cryptogenic localization-related epilepsies en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=OhtaHodaka en-aut-sei=Ohta en-aut-mei=Hodaka kn-aut-name=‘¾“c•ä‚ kn-aut-sei=‘¾“c kn-aut-mei=•ä‚ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1992 dt-pub=19920930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ƒ‰ƒbƒg‚Ä‚ñ‚©‚ñƒ‚ƒfƒ‹‚É‚¨‚¯‚é”]üð‘Ì’†‚ł̃‚ƒmƒAƒ~ƒ“•úo‚ÌŒoŽž•ω»‚Æ,ŠeŽí–ò•¨‚̉e‹¿‚ɂ‚¢‚Ä ”]“à“§Í–@‚ð—p‚¢‚½ŽÀŒ± en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‰Á‘¾‰p–¾ kn-aut-sei=‰Á‘¾ kn-aut-mei=‰p–¾ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1995 dt-pub=19950325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=“SƒCƒIƒ“—U“±‚Ä‚ñ‚©‚ñƒ‰ƒbƒg‹y‚ÑŽ©‘R”­Ç‚Ä‚ñ‚©‚ñE1ƒ}ƒEƒX‚Ì”]“à‚É‚¨‚¯‚é})-1-amino-1,3-cyclopentane-trans-dicarboxyli cacidtrans-ACPD) ‚É‚æ‚éinositol triphosphoric acid ¶¬‚ÉŠÖ‚·‚錤‹† kn-title=(})-1-AMINO-1,3-CYCLOPENTANE-TRANS-DICARBOXYKIC ACID (TRANS-ACPD) INDUCED INOSITOL TRIPHOSPHORIC ACID FORMATION IN THE BRAIN OF IRON-INDUCED EPILEPTIC RATS AND EPILEPTIC EL MICE en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=–å˜e‘å kn-aut-sei=–å˜e kn-aut-mei=‘å aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1962 dt-pub=19620606 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ŽÀŒ±“I‚Ä‚ñ‚©‚ñǂƂµ‚Ẵrƒ^ƒ~ƒ“B6Œ‡–Rƒ}ƒEƒX”]‚̶‰»Šw“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=–“–ì‰h kn-aut-sei=–“–ì kn-aut-mei=‰h aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1990 dt-pub=19901231 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‚Ä‚ñ‚©‚ñ”­ì‚É‚¨‚¯‚éNMDAŽó—e‘̂̕aˆö“I–ðŠ„ ƒLƒ“ƒhƒŠƒ“ƒOƒ‚ƒfƒ‹‚ð—p‚¢‚½ŽÀŒ±“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=•ÐŽR‚©‚Ù‚é kn-aut-sei=•ÐŽR kn-aut-mei=‚©‚Ù‚é aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1987 dt-pub=19870630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=“S‰–—U“±‚Ä‚ñ‚©‚ñŒ´«Å“_‘gD‚É‚¨‚¯‚éƒOƒAƒjƒWƒm‰»‡•¨‚̕ϓ®‚ÉŠÖ‚·‚錤‹† “Á‚Ƀ‰ƒWƒJƒ‹”½‰ž‚É‚æ‚éƒOƒAƒjƒWƒm‰»‡•¨‚̶¬‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=•Ÿ“‡³“o kn-aut-sei=•Ÿ“‡ kn-aut-mei=³“o aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2002 dt-pub=20020930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=’†S¥‘¤“ª•”‚Éž™”g‚ð‚à‚—ǫ¬Ž™‚Ä‚ñ‚©‚ñ‚Æ”ñ’èŒ^—Ç«•”•ª‚Ä‚ñ‚©‚ñ‚É‚¨‚¯‚邎Ÿ”]‹@”\áŠQ‚ÌŒŸ“¢ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=•ž•”{—¢ kn-aut-sei=•ž•” kn-aut-mei={—¢ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1990 dt-pub=19900930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=–«‚Ä‚ñ‚©‚ñŠˆ“®‚ðŽ¦‚·ƒ‰ƒbƒg‘å”]”玿‚É‚¨‚¯‚éƒAƒfƒmƒVƒ“Š´Žó«ƒTƒCƒNƒŠƒbƒNAMP‡¬Œn‚̉ž“š•ω» kn-title=Regional difference in responsiveness of adenosine-sensitive cyclic AMP-generating systems in chronic epileptic cerebral cortex of the rat en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=•ž•”K—Y kn-aut-sei=•ž•” kn-aut-mei=K—Y aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1964 dt-pub=19640930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ƒAƒ‚ƒoƒ‹ƒrƒ^[ƒ‹ƒ\[ƒ_èò“®–¬’ŽË‚É‚æ‚é‚Ä‚ñ‚©‚ñÅ“_‹ÇÝf’f‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=”ª–ØŒ’ kn-aut-sei=”ª–Ø kn-aut-mei=Œ’ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1994 dt-pub=19941231 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=‘I‘ð“IAMPAŽó—e‘ÌhR–ò, NBQX ‚̃‰ƒbƒg¥ƒLƒ“ƒhƒŠƒ“ƒOƒ‚ƒfƒ‹‚ɑ΂·‚é‚Ä‚ñ‚©‚ñŒ´«—\–hŒø‰Ê‚¨‚æ‚ÑR‚¯‚¢‚ê‚ñŒø‰Ê kn-title=Antiepileptogenic and anticonvulsant effects of NBQX, a selective AMPA receptor antagonist, in the rat kindling model of epilepsy en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=“ï”g‘½’ߎq kn-aut-sei=“ï”g kn-aut-mei=‘½’ߎq aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1984 dt-pub=19840331 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ƒqƒg‘‰t’†‚̃OƒAƒjƒWƒm‰»‡•¨‚ÉŠÖ‚·‚錤‹† “Á‚ɂĂñ‚©‚ñгŽÒ‚ɂ‚¢‚Ä en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=“¡–{¸ kn-aut-sei=“¡–{ kn-aut-mei=¸ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1995 dt-pub=19950630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ƒAƒfƒmƒVƒ“ŠÖ˜A•¨Ž¿‚É‚æ‚éŠO«‚Ä‚ñ‚©‚ñ”­Ç—\–h‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=“–^ƒ“ñ kn-aut-sei=“–^ kn-aut-mei=ƒ“ñ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1989 dt-pub=19890630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=“ñŽŸ‚Ä‚ñ‚©‚ñŒ´«Œ`¬‚ɉʂ½‚·ŠC”n‰“S˜H‚Ì–ðŠ„ G“ŠjƒLƒ“ƒhƒŠƒ“ƒOƒ‚ƒfƒ‹‚ð—p‚¢‚½ŽÀŒ±“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=’‡’n—¥—Y kn-aut-sei=’‡’n kn-aut-mei=—¥—Y aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1994 dt-pub=19940331 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=¬Ž™Šú‚ÌöÝ«‚Ä‚ñ‚©‚ñ‚Ì”]”g‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‘å–ì”É kn-aut-sei=‘å–ì kn-aut-mei=”É aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1993 dt-pub=19930930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=¬Ž™Šú‚É‚¨‚¯‚é’x”­«‚Ä‚ñ‚©‚ñ‚Ì—Õ°“I”]”gŠw“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‘å“ú•ûC kn-aut-sei=‘å“ú•û kn-aut-mei=C aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1961 dt-pub=19610331 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ŠeŽí‚Ä‚ñ‚©‚ñ‚ɑ΂µƒÁˆêƒAƒ~ƒm—Ž_•À‚ÉŠÖ˜A•¨Ž¿‚Ì‹y‚Ú‚·‰e‹¿‚ÉŠÖ‚·‚é—Õ°“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‘å“cŒ´r•ã kn-aut-sei=‘å“cŒ´ kn-aut-mei=r•ã aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1985 dt-pub=19850630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=¬Ž™‚Ä‚ñ‚©‚ñ‚É‚¨‚¯‚é’f–ò‰ß’ö‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‘å’˔Ўq kn-aut-sei=‘å’Ë kn-aut-mei=”ÐŽq aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1995 dt-pub=19950331 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=¶Œã6ƒ•ŒŽ–¢–ž”­Ç‚Ì‹ÇÝŠÖ˜A«‚Ä‚ñ‚©‚ñ‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‘åŽçˆÉD kn-aut-sei=‘åŽç kn-aut-mei=ˆÉD aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1999 dt-pub=19990325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=ƒ‰ƒbƒgG“Šj‚¨‚æ‚ÑŠC”nƒLƒ“ƒhƒŠƒ“ƒO”­ì‚É‚¨‚¯‚餃‰ƒ‚ƒgƒŠƒMƒ“‚¨‚æ‚Ñ]—ˆ‚ÌR‚Ä‚ñ‚©‚ñ–ò‚ÌŒø‰Ê kn-title=Effects of lamotrigine and conventional antiepileptic drugs on amygdala- and hippocampal-kindled seizures in rats en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‘匎Œ’˜Y kn-aut-sei=‘匎 kn-aut-mei=Œ’˜Y aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1997 dt-pub=19971231 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‘¤“ª—t‚Ä‚ñ‚©‚ñ‚É‚¨‚¯‚éBenzodiazepine Receptor Imaging SPECT‚ÌŒŸ“¢ 123I-IMP SPECT‚Ƃ̔äŠr en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‘¥´‘ב¢ kn-aut-sei=‘¥´ kn-aut-mei=‘ב¢ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1991 dt-pub=19910930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ƒRƒoƒ‹ƒg—U“±‚Ä‚ñ‚©‚ñ«‘å”]”玿‚̃TƒCƒNƒŠƒbƒNAMP‡¬Œn‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=ó–ØGŽ÷ kn-aut-sei=ó–Ø kn-aut-mei=GŽ÷ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year= dt-pub= dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‘¤“ª—t‚Ä‚ñ‚©‚ñ‚É‚¨‚¯‚éŽüšk—̔玿 (perirhinal cortex)‚Ì–ðŠ„ ƒLƒ“ƒhƒŠƒ“ƒOƒlƒR‚ð—p‚¢‚½ŽÀŒ±“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=Ü“c‹Å® kn-aut-sei=Ü“c kn-aut-mei=‹Å® aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1981 dt-pub=19811231 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ƒRƒoƒ‹ƒg‚Ä‚ñ‚©‚ñŒ¹«Å“_‘gD‚̃¿-guanidinoglutaric acid ‹y‚Ñ‚»‚Ì‘¼‚Ì guanidino ‰»‡•¨‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=ԖسK kn-aut-sei=Ô–Ø kn-aut-mei=³K aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1984 dt-pub=19840930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‰ªŽRŒ§‚É‚¨‚¯‚鬎™‚Ä‚ñ‚©‚ñ‚Ì_Œo‰uŠw“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=Γcƒ˜Y kn-aut-sei=Γc kn-aut-mei=ƒ˜Y aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1996 dt-pub=19960325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=™”g‡–°Šú‚ÉŽ‘±«ž™™”g‚ðŽ¦‚·‚Ä‚ñ‚©‚ñ‚Ìc’f“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=¼—Ñ®—S kn-aut-sei=¼—Ñ kn-aut-mei=®—S aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1986 dt-pub=19860331 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=“S‰–—U“±Å“_«‚Ä‚ñ‚©‚ñ‚Ì”]”gŠw“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=¼“c‹X‰Â kn-aut-sei=¼“c kn-aut-mei=‹X‰Â aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1988 dt-pub=19880630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=‚Ä‚ñ‚©‚ñ”­ì”­Œ»‹@˜‚ÉŠÖ‚·‚éŽÀŒ±“IŒ¤‹† ‘æ1•Ò:ƒLƒ“ƒhƒŠƒ“ƒOŽhŒƒ’†‚Ì”]”g•ω»:GABA«—}§‚Ì‹•’E‚Æ rhythmic synchronous burst ‚Ì”­Œ») ‘æ2•Ò:ƒLƒ“ƒhƒŠƒ“ƒOŽhŒƒ’†‚Ì”]”g•ω»:‡U.Ž©”­‚¨‚æ‚Ñ—U”­“dˆÊ‚Ì”äŠr) ‘æ3•Ò:ƒLƒ“ƒhƒŠƒ“ƒOŽhŒƒ’†‚Ì”]”g•ω»:‡V.ŽhŒƒG“Šj‚ɑ΂·‚é–ò—Šw“I‘€ì) kn-title=‘æ1•Ò@:@Kindling@induced@changes@in@EEG@recorded@during@stimulation@from@the@site@of@stimulation@:@Collapse@of@GABA|mediated@inhibition@and@onset@of@rhythmic@synchronous@burst@@‘æ2•Ò@:@Kindling-induced@changes@in@the@EEG@recorded@during@stimulation@from@the@site@of@stimulation@:@‡U.@Comparison@between@spontaneous@and@evoked@potentials@@‘æ3•Ò@:@Kindling|inducedcd@changes@in@EEG@recorded@during@stimulation@from@the@site@of@stimulation@:@‡V.@Direct@pharmacological@manipulations@of@the@kindled@amygdala en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=X–{´ kn-aut-sei=X–{ kn-aut-mei=´ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1997 dt-pub=19970630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=R‚Ä‚ñ‚©‚ñ–òƒtƒFƒmƒoƒ‹ƒrƒ^[ƒ‹‚ÌŒŒ’†“®‘Ô‚É‚¨‚æ‚Ú‚·”DP¥Žö“û‚̉e‹¿‚ÉŠÖ‚·‚錤‹† ‘æ1•Ò(ƒtƒFƒmƒoƒ‹ƒrƒ^[ƒ‹‚ÌŒŒ’†“®‘Ô‚É‚¨‚æ‚Ú‚·”DP‚̉e‹¿)‘æ2•Ò(ƒtƒFƒmƒoƒ‹ƒrƒ^[ƒ‹‚ÌŒŒ’†“®‘Ô‚É‚¨‚æ‚Ú‚·Žö“û‚̉e‹¿) kn-title=‘æ1•Ò Effect of Pregnancy on Plasma Phenobarbital Concentrations in Rats ‘æ2•Ò Influence of Lactation on Plasma Phenobarbital Concentrations in Rats en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=XŽR‰ëO kn-aut-sei=XŽR kn-aut-mei=‰ëO aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1997 dt-pub=19970325 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=G“ŠjƒLƒ“ƒhƒŠƒ“ƒO‚³‚ꂽ‚Ä‚ñ‚©‚ñŒ¹«‚ÌŽüšk—̔玿‚É‚¨‚¢‚Äin vitro‚Å‹L˜^‚³‚ê‚é‚Ä‚ñ‚©‚ñ—l‚Ìê‚Ì“dˆÊ‚Ì“Á« kn-title=Characterization of epileptiform field potentials recorded in the in vitro perirhinal cortex of amygdala-kindled epileptogenesis en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=¼–{—m•ã kn-aut-sei=¼–{ kn-aut-mei=—m•ã aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1985 dt-pub=19850331 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=¬Ž™‚Ä‚ñ‚©‚ñ‚É‚¨‚¯‚éo¶‘O—vˆö‚ÌŒŸ“¢ ‘æ1•Ò:o¶‘O—vˆö‚ÉŠî‚­‚Ä‚ñ‚©‚ñ‚Ì—Õ°“IŒ¤‹† ‘æ2•Ò:o¶‘O—vˆö‚ÉŠî‚­‚Ä‚ñ‚©‚ñ‚Ì”]”g‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=¼“c“s kn-aut-sei=¼“c kn-aut-mei=“s aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1988 dt-pub=19880930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‘å”]•Ó‰ŒnƒLƒ“ƒhƒŠƒ“ƒO‚É‚æ‚郃^ƒ“ƒtªƒ^ƒ~ƒ“ƒw‚Ì”½‰ž«‚̕ω» ‚Ä‚ñ‚©‚ñ«s“®ˆÙí‚ÌŽÀŒ±“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=HŽRFŽq kn-aut-sei=HŽR kn-aut-mei=FŽq aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1991 dt-pub=19910328 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=”N—îˆË‘¶«‚Ä‚ñ‚©‚ñ«”]Ç‚Ìc’f“IŒ¤‹† kn-title=Age-Dependent Epileptic Encephalopathy : a Longitudinal Study en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=ŽR–NŽq kn-aut-sei=ŽR– kn-aut-mei=NŽq aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=2002 dt-pub=20020630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=ƒqƒhƒƒLƒVƒ‹ƒ‰ƒWƒJƒ‹Á‹ŽÜ‚Å‚ ‚郿-ƒgƒRƒtªƒŠƒ‹-L-ƒAƒXƒRƒ‹ƒrƒ“Ž_-2-ƒÍ-ƒŠƒ“Ž_ƒWƒGƒXƒeƒ‹‚ÍŠO«‚Ä‚ñ‚©‚ñƒ‚ƒfƒ‹ƒ‰ƒbƒg‚̂Ăñ‚©‚ñW“_Œ`¬‚ð‘jŽ~‚·‚é kn-title=ƒ¿-Tocopheryl-L-ascorbate-2-ƒÍ-phosphate diester, a hydroxyl radical scavenger, prevents the occurrence of epileptic foci in a rat model of post-traumatic epilepsy en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=ŽR–{“ñ•½ kn-aut-sei=ŽR–{ kn-aut-mei=“ñ•½ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1997 dt-pub=19970930 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=V‹KR‚Ä‚ñ‚©‚ñ–òƒ‰ƒ‚ƒgƒŠƒMƒ“‚ÌŒŒ’†“®‘Ô‚ÉŠÖ‚·‚錤‹† ‘æ1•Ò(ŒÅ‘Š’Šo–@‚ð—p‚¢‚½HPLC‚É‚æ‚éƒqƒgŒŒ´’†‚ÌV‹KR‚Ä‚ñ‚©‚ñ–òƒ‰ƒ‚ƒgƒŠƒMƒ“‚̊ȕւ©‚Âv‘¬‚È•ªÍ) ‘æ2•Ò(V‹KR‚Ä‚ñ‚©‚ñ–òƒ‰ƒ‚ƒgƒŠƒMƒ“‚ÌŒŒ’†“®‘Ô‚É‹y‚Ú‚·Ží[R‚Ä‚ñ‚©‚ñ–ò‚̉e‹¿) kn-title=‘æ1•Ò@Simple@and@rapid@analysis@of@lamotrigine, a novel@antiepileptic,in@human@serum@by@high-performance@liquid@chromatography@using@a@solid-phase@extraction@technique@‘æ2•Ò@@Effects@of@various@antiepileptic@drugs@on@plasma@levels@of@lamotrigine,a@novel@antiepileptic,in@rats@ en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=ŽR‰ºÍˆê kn-aut-sei=ŽR‰º kn-aut-mei=͈ê aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1990 dt-pub=19901231 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=Ž©‘R”­Ç‚Ä‚ñ‚©‚ñƒ‚ƒfƒ‹‚Å‚ ‚éElƒ}ƒEƒX‚É‚¨‚¯‚é”]“àTRHŒn‚̕ω» kn-title=Changes in Brain Thyrotropin-Releasing Hormone (TRH) of Seizure-Prone El Mice en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=ŽR‰ºŒöŽO˜Y kn-aut-sei=ŽR‰º kn-aut-mei=ŒöŽO˜Y aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1984 dt-pub=19841231 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=ŒõŠ´Žó«‚Ä‚ñ‚©‚ñ‚ÉŠÖ‚·‚é—Õ°“I”]”gŠw“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=ŽO‘îi kn-aut-sei=ŽO‘î kn-aut-mei=i aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1966 dt-pub=19660331 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=•ª—ô•a—l•a‘œ‚ð—L‚·‚é‚Ä‚ñ‚©‚ñ—Õ°“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=×ì´ kn-aut-sei=×ì kn-aut-mei=´ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1983 dt-pub=19830331 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=“SƒCƒIƒ“‚Ä‚ñ‚©‚ñŒ¹«Å“_‘gD‚̃tƒŠ[ƒ‰ƒWƒJƒ‹”½‰ž‚Æ”­ì”­Œ»‹@\‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‚’mGŠì kn-aut-sei=‚’m kn-aut-mei=GŠì aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1980 dt-pub=19800331 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‚Ä‚ñ‚©‚ñ‚ÌŽ¡—×\Œã en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‹v‹½•q–¾ kn-aut-sei=‹v‹½ kn-aut-mei=•q–¾ aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1978 dt-pub=19781231 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=¬Ž™Šú‚̑唭ì‚Ä‚ñ‚©‚ñ‚ÉŠÖ‚·‚é—Õ°“I”]”gŠw“IŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=Š¡“cã`ˆê˜Y kn-aut-sei=Š¡“c kn-aut-mei=ã`ˆê˜Y aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1990 dt-pub=19900630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=“SƒCƒIƒ“”]“à’“ü‚É‚æ‚éŽÀŒ±“I‚Ä‚ñ‚©‚ñŒ´«Å“_‘gD‚É‚¨‚¯‚é acetylcholine ‘ãŽÓ‚ÌŒ¤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‰Íã—Y”V‰î kn-aut-sei=‰Íã kn-aut-mei=—Y”V‰î aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1990 dt-pub=19900630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title=ƒ‰ƒbƒg“S‰–—U“±‚Ä‚ñ‚©‚ñŒ´«Å“_‚É‚¨‚¯‚éƒAƒ~ƒmŽ__Œo“`’B•¨Ž¿‚ÉŠÖ‚·‚錤‹† kn-title=Amino Acid Neurotransmitters in Iron-Induced Epileptic Foci of Rats en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‰–“cŒú kn-aut-sei=‰–“c kn-aut-mei=Œú aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1995 dt-pub=19950630 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=‰ü—ÇŒ^_Œo“`’B•¨Ž¿•úo‘ª’è‘•’u‚É‚æ‚éE1ƒ}ƒEƒXŠC”nؕЂæ‚è‚Ì_Œo“`’B•¨Ž¿•úo‚ÆR‚Ä‚ñ‚©‚ñ–òƒ]ƒjƒTƒ~ƒh‚̉e‹¿‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name= en-aut-sei= en-aut-mei= kn-aut-name=‰““¡“Ö kn-aut-sei=‰““¡ kn-aut-mei=“Ö aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw END start-ver=1.4 cd-journal=joma no-vol= cd-vols= no-issue= article-no= start-page= end-page= dt-received= dt-revised= dt-accepted= dt-pub-year=1985 dt-pub=19851231 dt-online= en-article= kn-article= en-subject= kn-subject= en-title= kn-title=“S‰–—U“±‚Ä‚ñ‚©‚ñ«‘å”]”玿‚̃TƒCƒNƒŠƒbƒNAMP‡¬Œn‚ÉŠÖ‚·‚錤‹† en-subtitle= kn-subtitle= en-abstract= kn-abstract= en-copyright= kn-copyright= en-aut-name=YasuharaHiromichi en-aut-sei=Yasuhara en-aut-mei=Hiromichi kn-aut-name=ˆÀŒ´O’Ê kn-aut-sei=ˆÀŒ´ kn-aut-mei=O’Ê aut-affil-num=1 ORCID= affil-num=1 en-affil= kn-affil=‰ªŽR‘åŠw en-keyword=“S‰–—U“±‚Ä‚ñ‚©‚ñ«‘å”]”玿 kn-keyword=“S‰–—U“±‚Ä‚ñ‚©‚ñ«‘å”]”玿 en-keyword=ƒTƒCƒNƒŠƒbƒNAMP‡¬Œn kn-keyword=ƒTƒCƒNƒŠƒbƒNAMP‡¬Œn END